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Given that children with Attention-Deficit/Hyperactivity Disorder (AD/HD) are 
known to experience difficulties with anxiety at a higher rate than the general population, 
this study’s overall goal was to examine potential risk factors that may explain the link 
between AD/HD and comorbid anxiety.  Sixty-three male and female children diagnosed 
with AD/HD and their mothers were administered various questionnaires to assess six 
domains (demographics, faulty thinking, parenting factors, school functioning, treatment, 
and AD/HD severity) to ascertain possible risk factors for the development of comorbid 
anxiety.  In addition, mothers were administered a diagnostic interview to assess their 
children’s AD/HD and separate anxiety diagnoses.  Results supported variables most 
consistently in the faulty thinking, parenting factors, and school functioning domains as 
potential risk factors contributing to comorbid anxiety in children with AD/HD.  Contrary 
to expectations, AD/HD severity made no direct contribution to comorbid anxiety above 
and beyond the other variables.  However, it most likely makes an indirect contribution 
by its impact on the faulty thinking, parenting factors, and school functioning domains.  
Further, although causality cannot be addressed by the current research design, the three 
identified domains serve as a foundation for future research targeting directionality and 
risk in the development of anxiety among children with AD/HD.  Based on this study’s 
findings, implications for assessments and treatments for clinical practice were also 
discussed.
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CHAPTER I 
INTRODUCTION 
 
 
One of the most common difficulties for which children are referred for 
psychological evaluations and treatment is Attention-Deficit/Hyperactivity Disorder 
(AD/HD; American Psychiatric Association, 1994; Cantwell, 1996; National Institutes of 
Health, 2000).  Approximately 3% to 5% of school-aged children develop this disorder.  
Many of these children display or go on to develop secondary or comorbid conditions 
including learning difficulties, social skills deficits, externalizing problem behaviors, and 
internalizing difficulties (Barkley, 1998; Barkley, Anastopoulos, Guevremont, & 
Fletcher, 1992; Befera & Barkley, 1985; Cantwell & Baker, 1992; Cuffe, Moore, & 
McKeown, 2005; DuPaul & Stoner, 1994; Pelham & Bender, 1982).  Although a 
significant percentage of children with AD/HD exhibit problems beyond those due to the 
core symptoms of the disorder, little is known about the development of comorbid 
conditions.  Compared to research on comorbid learning difficulties and externalizing 
problems among children with AD/HD, even less is known regarding the development of 
comorbid internalizing problems, specifically anxiety difficulties (Jensen et al., 2001).   
What is known is that anxiety disorders are present among children with AD/HD 
at a higher rate than in the general population (Angold, Costello, & Erkanli, 1999).  
Studies have indicated that anywhere from 25% to 50% of children with AD/HD display 
some type of anxiety disorder (Anderson, Willliams, McGee, & Silva, 1987; August, 
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Realmuto, MacDonald, Nugent, & Crosby, 1996; Biederman, Faraone, & Lapey, 
1992; Bird, Gould, & Staghezza, 1993; Busch et al., 2002; Cohen, Cohen & Kasen, 1993; 
Jensen, Martin, & Cantwell, 1997; Russo & Biedel, 1994) compared to 5% to 21% of 
children without AD/HD in the general population (Busch et al., 2002; Kashani & 
Orvaschel, 1990; Pliszka, 2000).  Although many children with AD/HD exhibit comorbid 
anxiety, many do not develop this type of problem.  What is unknown is how anxiety 
develops in children with AD/HD.  In the AD/HD population, multiple pathways are 
likely to exist to bring about comorbid anxiety, and the timing of these pathways is 
unclear.  Core anxiety symptoms may precede the development of AD/HD symptoms, the 
opposite may occur, or perhaps the presence of both difficulties occurs simultaneously.   
To facilitate understanding of how comorbid anxiety may develop in children 
with AD/HD, a review of each of these disorders will be presented first, including 
sections on current diagnostic criteria, epidemiology, developmental course, and etiology.  
Next, an examination of the research on AD/HD and comorbid anxiety and its limitations 
will be highlighted to aid in determining gaps that current and future research may target.  
Finally, a conceptual framework of potential risk factors associated with the presence of 
anxiety in children with AD/HD will be presented as a needed next step in this line of 
research.   
Overview of AD/HD 
 AD/HD is a disorder characterized by developmentally deviant levels of 
inattention and/or hyperactivity-impulsivity (American Psychiatric Association, 1994).  
Inattentive symptoms include behaviors such as having difficulty sustaining attention, 
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making careless errors in one's work, and being easily distracted.  Hyperactive-impulsive 
symptoms include behaviors such as fidgeting and squirming when seated, running 
around or climbing excessively in inappropriate situations, being "on the go" or acting as 
if "driven by a motor," and having difficulty waiting for a turn.  Not only must a 
diagnosis be based upon the presence of these symptoms, but a child must also display a 
pervasive and chronic pattern of inattentive and/or hyperactive-impulsive behaviors in 
excess of what would be expected of other children of the same age (American 
Psychiatric Association, 1994).   
Current diagnostic criteria 
In the current Diagnostic and Statistical Manual of Mental Disorders - Fourth 
Edition (DSM-IV), two lists of symptoms are provided, one for inattentive behaviors and 
one for hyperactive-impulsive behaviors.  Six of nine symptoms from the inattention list 
and/or six of nine symptoms from the hyperactivity-impulsivity list must be endorsed as 
developmentally deviant in order to meet the symptom frequency criteria for a diagnosis 
of AD/HD.  In addition, the symptoms must have persisted for at least 6 months, be 
present prior to age seven, and be associated with clinically significant impairment in two 
or more settings (e.g., home, school, daycare).  Finally, these symptoms cannot be 
attributable to other mental or behavioral disorders.  One of three major types of AD/HD 
diagnoses can be determined from criteria met for either or both symptoms lists:  
Predominantly Inattentive Type (AD/HD-I), Predominantly Hyperactive-Impulsive Type 
(AD/HD-HI), and Combined Type (AD/HD-C; American Psychiatric Association, 1994).  
AD/HD-I is diagnosed when at least six of nine inattentive symptoms and five or less 
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hyperactive-impulsive symptoms are endorsed.  AD/HD-HI is diagnosed when at least 
six of nine hyperactive-impulsive symptoms and five or less inattentive symptoms are 
exhibited.  Finally, AD/HD-C can occur when at least six of nine inattentive symptoms 
and at least six of nine hyperactive-impulsive symptoms are present. 
Epidemiology 
 The prevalence of AD/HD in school-aged children is estimated at 3-5% of the 
general population (American Psychiatric Association, 1994; Cuffe et al., 2005).  
However, studies examining AD/HD have reported prevalence rates ranging from a low 
of 2% to as high as 25% (Gadow et al., 2000; Gaub & Carlson, 1997; Nolan, Gadow, & 
Sprafkin, 2001; Szatmari, 1992).  The prevalence of AD/HD has been found to vary 
significantly as a function of gender, with the disorder being evident much more 
frequently in males than in females.  Male-to-female ratios range from 4:1 to 9:1 
depending on the sample (i.e., general population or clinic population).  Prevalence rates 
are also affected by age considerations with rates of the disorder appearing to decrease 
with age (DuPaul et al., 1997).  The role of socioeconomic status (SES) on prevalence 
rates of AD/HD is inconsistent, with some research reporting slightly higher rates in 
lower SES groups while others show comparable rates across social classes when 
comorbid conditions are controlled (Lambert, Sandoval, & Sassone, 1978; Szatmari, 
1992).  Ethnic differences have also been documented suggesting a higher rate of AD/HD 
symptoms among ethnic minority children when compared to Caucasian children 
(Bauermeister, Berrios, Jimenez, Acevedo, & Gordon, 1990; DuPaul et al., 1997).        
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Developmental Course 
 The expression of AD/HD symptoms changes across development.  The onset of 
these symptoms usually occurs during the preschool years at about 3 to 4 years old 
(Barkley, 1996).  Hyperactive-impulsive behaviors typically characterize the disorder at 
this age followed by developmentally deviant inattentive behaviors between 5 and 7 years 
of age.  Hyperactive-impulsive symptoms have been found to steadily decrease over time, 
while inattentive symptoms remain relatively constant (DuPaul et al., 1998; DuPaul et al., 
1997).  As children diagnosed with AD/HD develop into adolescents, about 50% to 80% 
will continue to experience difficulties and meet full diagnostic criteria for the disorder 
(Barkley, Fischer, Edelbrock, & Smallish, 1990; Mannuzza & Klein, 1992).  An 
estimated 30% to 50% of these adolescents with AD/HD will continue to display 
symptoms into adulthood (Barkley, 1996).  Even though as adults, individuals often do 
not continue to meet criteria for a formal AD/HD diagnosis, they still carry residual 
symptoms. 
Etiology 
Because most research points to the etiology of AD/HD as biological in nature, 
these factors receive much more attention than purely psychosocial causes.  Psychosocial 
factors are generally not thought to play a major etiological role (Barkley, 1990; 
Cantwell, 1996).  The main biochemical theory of AD/HD has been based on a 
catecholamine hypothesis, but its impact on AD/HD still remains unclear (Pliszka, 
McCracken, & Maas, 1996).  Studies on the place of action of methylphenidate point to 
dopamine being the most influential neurotransmitter involved in the presence of AD/HD 
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symptoms (Swanson, Castellanos, Murias, LaHoste, & Kennedy, 1998).  Rogeness, 
Javors, and Pliszka (1992) hypothesize that AD/HD can be seen as a result of 
dysregulation or imbalance of three neurotransmitter systems: the dopaminergic system, 
the noradrenergic system, and the serotonergic system.  It is unclear, however, the exact 
imbalance that is necessary for the development of AD/HD (Quist & Kennedy, 2001).   
 Studies are increasingly reporting possible genetic linkages for AD/HD.  To date, 
the strongest evidence for heritability of AD/HD comes from twin studies with greater 
concordance for AD/HD symptoms occurring between monozygotic (MZ) twins 
compared to dizygotic (DZ) twins.  In a review of 20 national and international twin 
studies of AD/HD, Faraone et al. (2005) found a mean heritability estimate of 76%.  The 
estimated heritability of AD/HD ranges from 0.5 to 0.9.  However, it has been proposed 
that the higher estimates are found in studies using symptom counts rather than 
categorical diagnoses.  When children who meet clinically significant diagnostic criteria 
for AD/HD were used in a study assessing heritability, the results revealed a heritability 
of 64 % for hyperactivity and inattention.  This finding may indicate genetics may be 
contributing more to the development of AD/HD in children who exhibit clinically 
significant levels of AD/HD symptoms (Todd, 2000).  
 Results from family studies and adoption studies provide further evidence that is 
consistent with genetics being a major contributor to the development of AD/HD.  For 
example, there is a higher prevalence of psychopathology in the parents, siblings, and 
other family members of children with AD/HD.  More specifically, it has been found that 
between 10% and 35% of parents and siblings of children with AD/HD also have the 
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disorder (Biederman, Faraone, Keenan, & Tsuang, 1991; Faraone & Biederman, 2000; 
Pauls, 1991).  Research from adoption studies also demonstrates that adopted children 
were more likely to show levels of hyperactivity that resembled the behavior of their 
biological parents rather than their adoptive parents (Sprich, Biederman, Crawford, 
Mundy, & Faraone, 2000; Todd, 2000). 
 More recently, researchers have begun to investigate more extensively the genes 
involved in AD/HD.  Molecular genetic studies suggest that AD/HD may be very 
complex and involve the contribution of several genes.  Mixed support has been found in 
candidate gene studies of AD/HD which have focused on catecholaminergic, 
noradrenergic, and serotonergic genes.  Faraone et al. (2005) reviewed candidate gene 
studies of AD/HD based on case-control and family-based designs and found substantial 
support for the following gene variants mostly associated with the dopamine and 
serotonin systems:  DRD4, DRD5, DAT, DBH, 5-HTT, HTR1B, and SNAP-25.  
Whether AD/HD is transmitted by one or more related or independent genes is still 
unknown, although there is mounting evidence that AD/HD is likely caused by many 
genes of small effect (Faraone et al. 2005; Khan & Faraone, 2006; Waldman & Gizer, 
2006).  
Overview of Childhood Anxiety 
Compared to disruptive behavior disorders, less research has focused on 
childhood anxiety (Chorpita & Barlow, 1998; Pine, 1999).  However, in recent years 
researchers have begun to study more extensively the epidemiology and course of 
childhood anxiety disorders.  Children with clinical levels of anxiety are characterized by 
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experiencing developmentally inappropriate fear or worry that is out of proportion to the 
context of the situation causing impairment in functioning.  The DSM-IV currently 
defines 10 clinical anxiety disorders that can affect children:  separation anxiety disorder, 
specific phobia, generalized anxiety disorder, social phobia, panic disorder with and 
without agoraphobia, agoraphobia without panic disorder, obsessive-compulsive disorder, 
posttraumatic stress disorder, and acute stress disorder (American Psychiatric 
Association, 1994).  
Current diagnostic criteria 
Due to the large number of childhood anxiety disorders, only the two of most 
interest to this study and which have been found to be commonly comorbid with AD/HD  
- Generalized Anxiety Disorder (GAD) and Social Phobia - will be described here  
(Manassis, Tannock, & Barbosa, 2000; Pine, 1997; Willcutt, Pennington, Chhabildas, 
Friedman, & Alexander, 1999).  According to criteria in the DSM-IV, in Generalized 
Anxiety Disorder, the anxiety symptoms are not bound to any discernible stimulus 
situation.  Excessive worry pervades a wide range of events and activities.  This 
excessive worry and anxiety are characteristic of the child's life for at least 6 months and 
are evidenced by one of six symptoms, i.e., restlessness, fatigue, sleep problems, inability 
to concentrate.  In Social Phobia, the anxiety is marked by a fear or worry of social or 
performance situations in which the child may feel embarrassed.  Children may or may 
not recognize that their worry is unreasonable.  These feelings of worry must have 
existed for 6 months in order to receive a diagnosis (American Psychiatric Association, 
1994). 
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Epidemiology 
The prevalence rate of anxiety is somewhat more complicated to estimate than 
that of AD/HD due to the number of separate disorders.  Population studies generally find 
around 5% to 21% of children reporting symptoms consistent with anxiety disorders 
(Kashani & Orvaschel, 1990; Pliszka, 2000).  As reviewed in Pine (1997), among the 10 
DSM-IV childhood anxiety disorders, Separation Anxiety Disorder, Specific Phobia, and 
Generalized Anxiety Disorder are the most common with prevalence estimates in the 2% 
to 5% range.  Panic Disorder is the rarest of the anxiety disorders occurring in <1% of 
children.  In general, anxiety is experienced at equal rates between male and female 
children during childhood with a split emerging at some point during adolescence with 
girls experiencing more difficulties with anxiety than boys.  This pattern varies somewhat 
across studies and anxiety disorders.  In respect to the two primary anxiety disorders of 
interest in this study, GAD appears to follow the above pattern (see reviews, Costello, 
Egger, & Angold, 2004; Flannery-Schroeder, 2004) whereas research is mixed in the case 
of Social Phobia, with some supporting that equal rates appear to be maintained (Beidel, 
Turner, & Morris, 1999) and other research supporting a split in adolescence (Essau, 
Conradt, & Petermann, 1999). 
Developmental Course  
 In a review of age of onset of childhood anxiety disorders in community and 
clinic samples, studies indicated that the onset age of anxiety disorders precedes that of 
depressive disorders in childhood (Kovacs & Devlin, 1998).  Onset age was defined as 
the earliest age at which the participants experienced any core symptoms of a particular 
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anxiety disorder.  The mean onset age of GAD has been reported as 8.8 years and the 
mean onset age of Social Phobia was 11 years (Last, Perrin, Hersen, & Kazdin, 1992).  
Other studies have found the mean age of onset of GAD ranging from 10.8 to 13.4 years 
and the mean onset of Social Phobia ranging from 11.3 to 12.7 years (see review Beidel 
& Turner, 2005). 
 Views on childhood anxiety have gradually undergone change.  Whereas 
childhood worries and fears were historically thought to be transient in nature and were a 
neglected area of research, anxiety problems are now recognized as being a more stable 
and prevalent childhood difficulty.  Last, Perrin, Hersen, and Kazdin (1996) found that 
81.7% of clinically referred children 5-18 years old with anxiety disorders had recovered 
from their initial anxiety diagnosis at the end of a 3-4 year follow-up period with few 
cases (7.8%) of relapse during this period.  However, approximately 30% of these 
children developed new psychological diagnoses, usually a different anxiety disorder but 
a few developed behavior disorders or depressive disorders indicating continued clinical 
problems.  In a review by Beidel and Turner (2005), anxiety disorders across childhood 
and adolescence are present for considerable amounts of time.  Although rates vary, 
approximately 50% of children were found to meet criteria for their initial anxiety 
diagnosis at follow-up which ranged from 6 months to 5 years.  Twenty-five to 30% of 
the children were diagnosed with different anxiety disorders at follow-up which were 
hypothesized to have developed due to possible changes in the form of the disorder, child 
development, or diagnostic procedures.  Examining the developmental changes of 
childhood anxiety symptoms and fears in a community sample emphasized the need to 
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keep in mind developmental changes when studying the developmental course of clinical 
anxiety (Weems & Costa, 2005).  Separation anxiety was found to be most prominent in 
children 6-9 years old, death and danger fears in children 10-13 years old, and social 
anxiety in addition to fear of criticism in adolescents 14-17 years old.  Although the 
pattern of anxiety in a clinical sample may not follow the same pattern as in a community 
sample, it is important to consider that developmental changes may change the clinical 
expression as well.  
It is generally accepted that in many cases there may be connections from anxiety 
in childhood and adolescence to adult anxiety disorders.  For example, findings suggest 
that approximately 45% of adolescents with anxiety disorders will have anxiety disorders 
in adulthood (Pine, Cohen, Gurley, Brook, & Ma, 1998).  In addition, in studies of adults 
with anxiety disorders, most retrospectively reported suffering from an anxiety disorder 
in childhood (Newman et al., 1996; Pine et al., 1998).  Prospective longitudinal studies 
are needed to determine the specific risk that childhood anxiety disorders may contribute 
to the pathway in developing adult anxiety disorders.   
Etiology 
It is generally recognized that children develop and maintain problems with 
anxiety through multiple pathways (i.e., equifinality; Cicchetti & Rogosch, 1996).  Both a 
biological predisposition as well as interactions among environmental factors are thought 
to contribute to anxiety disorders in children, and pathways may differ among children 
leading to the same outcome (anxiety disorder).  Children who may be at-risk for anxiety 
problems also do not react equally to the same environmental and psychosocial factors, 
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and thus, all at-risk children do not develop anxiety disorders (i.e., multifinality; Cicchetti 
& Rogosch, 1996; Morris, 2004).  Although multiple factors play a role in the 
development of anxiety in children, including both biological explanations as well as 
environmental explanations, the focus of this next section will be biological in nature 
with a more detailed examination of prominent psychosocial factors that contribute to the 
development of anxiety to follow in subsequent sections.   
Biological factors.  Biological explanations have been a focus in studying the 
development of childhood anxiety as anxiety disorders have been shown to aggregate in 
families (Merikangas, Avenevoli, Dierker, & Grillon, 1999).  Children of adults with 
anxiety disorders display increased rates of anxiety disorders (Fyer, Mannuzza, 
Chapman, Martin, & Klein, 1995; Last, Hersen, Kazdin, Orvaschel, & Perrin, 1991; 
Warner, Mufson, & Weissman, 1995).  From another perspective, first-degree relatives of 
children with anxiety disorders also exhibit increased rates of anxiety disorders (Fyer et 
al., 1995; Last et al., 1991).  More recently, studies have focused on examining the 
specificity of familial associations across the DSM-IV anxiety classifications (Pine, 
1997).  However, current theories and the majority of studies have revealed that there is a 
genetic predisposition to developing anxiety of various degrees rather than a specific 
disorder (Pine, 1999).  Twin studies of anxiety are generally consistent with the trend in 
research on childhood disorders that indicate genetic and nonshared environmental 
factors contribute to their development (Pine, 1997).  In a study of 6-year-old twins, 
Bolton et al. (2006) found that Separation Anxiety Disorder demonstrated a substantial 
heritability estimate of 73%, while Specific Phobias were 60%, suggesting that genetic 
          
 
13
effects may be more significant than environmental effects on early-onset anxiety 
disorders.  However, in general, child studies of anxiety have produced mixed results 
with some indicating substantial heritability estimates, while others indicating that 
familial transmission of anxiety was best explained by shared environment (Thapar & 
McGuffin, 1994; Topolski et al., 1997).  Legrand, McGue, and Iacono (1999) estimated 
trait anxiety heritability at 45% and that more transient anxiety was accounted for by 
environmental factors.  Other research has found that genetics contributes approximately 
30% to anxiety heritability with shared environment 20% and the remaining variance in 
childhood anxiety explained by nonshared environmental factors (see review Eley & 
Gregory, 2004).  Although there have been several studies exploring genes related to the 
serotonin and dopamine systems in attempts to identify genes underlying anxiety 
disorders, no specific genetic loci have been found and replicated in independent samples 
(Merikangas & Low, 2005). 
The genetic component of anxiety is often thought to be manifested early on as a 
type of temperament in young children.  The term temperament indicates an assortment 
of stable moods and behavioral patterns that are controlled or influenced by a person's 
biology.  Emerging in early child development, temperament is a construct made up of 
both physiological and psychological processes.  Temperament is the result of various 
environments acting on young children who inherit a particular physiology (Schwartz, 
Snidman, & Kagan, 1999).  When applied to childhood anxiety specifically, Kagan 
(1994) describes two categories of children - behaviorally inhibited and uninhibited.  
Inhibited (shy) children at 2 years of age typically stop their ongoing behavior, stop 
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talking, seek comfort from a parent or withdraw when faced with unfamiliar people or 
situations.  In contrast, uninhibited (sociable) children approach unfamiliar people and 
situations and are outgoing, sociable, and talkative.   
Research examining Kagan's inhibited temperament in early childhood as a 
precursor to later anxiety problems has produced some support.  Schwartz et al. (1999) 
found that there are certain components of an inhibited temperament that continue from 2 
years of age to early adolescence that predispose them to social anxiety.  Among 
adolescents who had been classified as inhibited or uninhibited at 2-years-old with both 
standardized interviews and observation, 34% were found to be impaired by generalized 
social anxiety compared to 9% who had been identified as uninhibited (Schwartz et al., 
1999).  These findings indicate that inhibition at an early age may be a risk factor for 
developing later social anxiety.  However, 66% of the original inhibited 2-year-olds did 
not develop impairing social anxiety, suggesting that environment and other psychosocial 
factors play an influential role in the development of anxiety. 
Prior, Smart, Sanson, and Oberklaid (2000) also conducted a longitudinal study to 
assess relationships between inhibited children and anxiety problems later in adolescence.  
As part of the Australian Temperament Project (ATP), children were identified as 
inhibited "shy" and uninhibited "not shy" at 4-8 months of age and were assessed during 
several subsequent waves of data collection.  Results showed that 42% of children rated 
as shy during 6 or more of 8 assessments in childhood developed anxiety problems in 
adolescence compared to 11% of the participants who were never identified as shy.  
However, only 20% of the children with anxiety problems in early adolescence were 
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rated as persistently shy in childhood, and only 9% of a subsample of the cohort who had 
been given an anxiety diagnosis had been rated as persistently shy in childhood.  Results 
again suggest other environmental factors most likely play a role in anxiety development. 
Shamir-Essakow, Ungerer, and Rapee (2005) examined the relationships among 
behavioral inhibition, attachment, and anxiety in 3-4 year old children to aid in clarifying 
the development of childhood anxiety by adding an environmental factor, parent-child 
relationship (attachment).  The greatest anxiety (indicated by the sum of the number of 
anxiety disorders for which a child met diagnostic criteria) in children was shown by 
those who were identified as behaviorally inhibited and insecurely attached, as well as 
having anxious mothers.  However, causal and directional conclusions could not be made 
due to concurrent data collection of the various indices. 
Because there are few longitudinal studies examining the effects of temperament 
and the existing ones used different methods to obtain their samples and used different 
measurements of this construct, it is difficult to make meaningful generalizations.  
However, it appears that this biological trait may put at least some behaviorally inhibited 
children at increased risk for developing anxiety problems.  With the interaction of 
additional environmental and psychosocial factors, behaviorally inhibited children may 
be at an even greater risk for anxiety disorders.   
Psychosocial factors.  Although various psychosocial factors (i.e., attachment, 
adverse peer relations, and stressful life events) have been proposed to increase risk in the 
pathway to difficulties with anxiety, only those of interest to this study will be examined.  
Supported by the Weems and Stickle (2005) model discussed in the next section and 
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previous research, cognitive processing distortions, cognitions regarding limited control, 
over-control and negative parenting practices, and parent psychopathology are some of 
the conceptual factors that have been identified as areas of risk for anxiety development.   
Negative cognitive errors or cognitive processing distortions have been associated 
with childhood anxiety.  Leitenberg, Yost, and Carroll-Wilson (1986) found that negative 
cognitive errors were used significantly more by both depressed and anxious children 
than unaffected children.  More recently, mixed results have emerged regarding types of 
negative cognitive errors distinguishing between children who have problems with 
anxiety and those who have problems with depression (Epkins, 2000; Leung & Poon, 
2001; Weems, Berman, Silverman, & Saavedra, 2001).  Examples of these cognitive 
errors are overgeneralizing (believing that a single negative outcome will occur in all 
similar future cases), catastrophizing (expecting the worst possible outcome based on the 
belief that it is most likely to happen), personalizing (believing oneself to be responsible 
for all bad things), and selective abstraction (focusing on only the negative aspects of a 
situation) and are the same ones that were first described as used by depressed adults by 
Beck, Rush, Shaw, and Emery (1979).  Kendall, Pimental, Rynn, Angelosante, and Webb 
(2004) proposed that the way in which children cognitive process is important because it 
gives behavior meaning and over time, children will interpret similar behaviors they 
experience in a similar style.  Thus, eventually children will expect behavior and become 
anxious in advance. 
Chorpita and Barlow (1998) conceptualize the development of childhood anxiety 
also as a result of faulty cognitions specifically in relation to children’s perception of 
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control.  This key construct is defined as having the ability to influence events and 
outcomes in the environment related to reinforcement.  During their early development, 
children experience limited control over events in their lives which leads to an increased 
generalized propensity to perceive various aspects of life as not within their personal 
control.  Anxiety is hypothesized as developing from limited control, unpredictability, or 
"helplessness" at one end of a continuum with the other end potentially being an extreme 
sense of no control, “hopelessness,” and depression  (Alloy, Kelly, Mineka, & Clements, 
1990; Chorptia & Barlow, 1998).   
More recently, Chorpita, Brown, and Barlow (1998) found that restricted 
opportunity for personal control that permeated family environments was associated with 
anxiety in children.  Thus, it is not necessarily the occurrence of a traumatic event in their 
early development that is associated with the development of childhood anxiety, but 
everyday interactions and outcomes within the family environment that children believe 
are not influenced by their own behavior.  This learned perception contributes to the 
adoption of using an external locus of control which is associated with anxiety.    
In regard to the development of anxiety, parenting practices that are characterized 
by high protection and over-control especially in conflictual situations may be associated 
with later anxiety disorders (Bogels & Brechman-Toussaint, 2006; Turner, Beidel, 
Roberson-Nay, & Tervo, 2003).  Over-control parenting practices include a parent who 
restricts the child from interacting in developmentally appropriate activities.  These 
parents may be likely to discourage children to think and act independently, disregard 
children’s different opinions, and frequently disrespect children’s viewpoints (Whaley, 
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Pinto, & Sigman, 1999). These kinds of parenting behaviors can also encourage a child to 
have an external locus of control which is thought to lead to feelings of helplessness.  In 
addition it can lead to a family environment that is low on expressiveness, that is feeling 
limited in being able to openly express feelings, opinions, etc. which can contribute to 
children developing a perception of limited personal control leading to anxiety (Chorpita 
et al., 1998; Turner et al., 2003).  Parental negativity is conceptualized as parenting 
practices that are low in warmth, critical, and rejecting.  These negative parenting 
practices are hypothesized to affect childhood anxiety by contributing to children’s 
cognitive processes and thereby developing a tendency to view their environment as more 
threatening.  In a review, Bogels and Brechman-Toussaint (2006), suggest further 
research is needed on both types of parenting practices, parental over-control and parental 
negativity, to clarify individual, interactional, and causal contributions to the 
development of childhood anxiety.     
These types of parenting practices have often been found in parents who have 
psychological difficulties themselves.  Mothers who have anxiety difficulties have been 
rated as more critical and controlling of their children compared to control mothers 
(Whaley et al., 1999).  They also demonstrated less affection, smiled less frequently, and 
were more negative while interacting with their children.  Mothers with high levels of 
anxiety have also been found to exhibit lower expectations of their anxious children’s 
coping abilities in stressful or challenging situations compared to mothers of children 
without anxiety disorders.  These mothers may unintentionally encourage anxious 
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behavior and coping styles in their children (Kortlander, Kendall, & Panichelli-Mindel, 
1997).     
 Integrative models.  Some researchers have begun to develop theoretical models  
describing the etiology of childhood anxiety disorders that call for the inclusion of both  
biological factors as well as various environmental and psychosocial factors (Fredman,  
Hirshfeld-Becker, Smoller, & Rosenbaum, 2003; Morris, 2004; Weems & Stickle, 2005).  
Childhood anxiety disorders are hypothesized to be produced by a complex interaction of 
biological, cognitive, behavioral, and social factors in various contexts (i.e., home, 
school, community).  Weems and Stickle (2005) proposed a general model of childhood 
anxiety with a tentative ordering of the theoretical processes.  They hypothesized that:  
 
biological factors may appear early in the development of anxiety disorders, that 
the interpersonal or social aspects are likely to affect some of the other processes, 
and that the cognitive and learning factors are proximal to the development of 
anxiety disorder and may be responsible for some specificity in order 
development (Weems & Stickle, 2005, p.113). 
 
 
As seen in Figure 1, the authors reiterate the concepts of equifinality and multifinality in 
that they suggest that different interactions of these factors may lead to the same outcome 
of an anxiety disorder.  They also propose that biological, cognitive, behavioral, and 
social protective factors exist as well that may prevent a child who experiences many of 
the risk factors from developing anxiety disorders.     
Fredman et al. (2003) also proposed a tentative general etiological model of 
anxiety acknowledging that questions regarding the specificity of risk factors for separate 
anxiety disorders and the mechanisms through which they contribute to disorders still 
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remain.  They proposed that children have a biological predisposition of low tolerance for 
physiological arousal and/or easily acquire fear regarding certain objects, places, or 
situations.  This predisposition may be exhibited as behavioral inhibition or a specific 
childhood anxiety disorder.  Environmental factors such as parental modeling of poor 
coping, critical parenting style, stressful live events, and negative peer relationships may 
interact with children’s “pre-existing biological diathesis” (Fredman et al., 2003, p.150) 
to shape children’s beliefs that they are unable to cope with a dangerous world and that 
anxiety symptoms and interactions with others are uncontrollable.   
 Morris (2004) suggested one possible pathway to a specific childhood anxiety 
disorder, Social Phobia, in which an infant who is behaviorally inhibited is raised by a 
parent with anxiety difficulties which impairs the parent’s ability to be nurturing and 
appropriately responsive to the child’s needs.  There may be a “poor fit between parent 
and child temperament styles” (Morris, 2004, p. 59) resulting in impaired attachment in 
parent-child relationships as well as subsequent relationships the child tries to initiate and 
maintain with peers.  Unable to practice and develop healthy, appropriate social skills, a 
child may withdraw and become isolated which may generalize across social settings, 
promoting and maintaining a negative cycle.  Morris (2004) explained that because there 
are “multiple entry points” (p. 59) on the pathway to the development of anxiety 
disorders in children, studying and understanding the etiology and course of anxiety 
disorders is challenging.   
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Comorbidity 
Following from the two previously reviewed childhood disorders, an examination 
of comorbidity is necessary as AD/HD and anxiety are often experienced together in 
children.  Historically, the term comorbidity has had various meanings.  These meanings 
originated in the medical literature.  In a diagnostic sense, comorbidity has been used to 
describe one disease exhibiting symptoms similar to a coexisting disease.  In a prognostic 
sense, comorbidity refers to the increased risk of negative outcome due to combination or 
individual effects of having co-occurring diseases.  In a pathogenetic sense, two diseases 
are related etiologically, not simply co-occurring.  Finally, comorbidity can be used in a 
therapeutic sense to describe how a disease can affect the evaluation of treatment efficacy 
of a co-occurring disease (Kaplan & Feinstein, 1974; Lilienfield, Waldman, & Israel, 
1994).  More recently, Lilienfield et al. (1994) made the argument that the term 
comorbidity should not be used in the psychopathology literature because it creates 
confusion as to what meaning is intended, particularly co-occurrence or covariation.  Co-
occurrence is simply the presence of two diagnoses while covariation is the presence of 
two diagnoses occurring more often than by chance.  In this paper, the term comorbidity 
will be used in the context of covariation; that is, that AD/HD and childhood anxiety have 
some similarities and occur together more frequently than by chance.  
The question of primary diagnosis is also relevant in understanding comorbidity 
research in this area.  Primary diagnosis can refer to the disorder that appeared first in a 
child’s history.  It can also refer to the diagnosis that is most important to the family, the 
diagnosis that is the focus of treatment, or the diagnosis that is causing the most 
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impairment in a child’s life.  In terms of this study, AD/HD is considered the primary 
diagnosis in that children who participated were recruited from an AD/HD clinic and 
research lab where they were referred for assessment due to questions of the presence of 
AD/HD. 
AD/HD and Anxiety Comorbidity Rates 
 Multiple pathways may lead to the presence of anxiety in children with AD/HD.  
Prevalence studies of children whose primary diagnosis is an anxiety disorder have found 
comorbid AD/HD rates ranging from 10% to 17% (Beidel et al., 1999; Swedo, Rapoport, 
Leonard, Lenane, & Cheslow, 1989; Verduin & Kendall, 2003).  In contrast, studies of 
children with AD/HD as the primary difficulty and comorbid anxiety have reported 
higher rates.  In clinic-referred samples, anxiety disorders are present in approximately 
25% to 50% of the AD/HD population (Biederman et al., 1992; Pliszka, 2000; Russo & 
Biedel, 1994).  In community samples, comorbid anxiety disorders occur in 25% to 40% 
of the AD/HD population (Anderson et al., 1987; August et al., 1996; Bird et al., 1993; 
Cohen et al., 1993; Jensen et al., 1997).  Within clinic and community samples, varying 
estimates are likely due to different diagnostic criteria and assessment tools, type and 
number of informants, and methods for obtaining samples (Jensen et al., 1997).  Higher 
rates of comorbidity in clinic-referred AD/HD samples have been suggested as an 
overestimation of true comorbidity in the general population.  Thus, elevated comorbidity 
in clinic populations is seen as a manifestation of more severe psychopathology and 
impairment in functioning, so that children with AD/HD and comorbid disorders are 
more likely to be referred for treatment than less severe noncomorbid AD/HD 
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(McConaughy & Achenbach, 1994).  However, studies with both clinic-referred samples 
and community samples have consistently shown that children with AD/HD have "co-
occurring" anxiety more often than by chance and cannot be attributed to solely factors 
such as referral biases and differences in diagnostic instruments, informants, or 
participant age (Angold et al., 1999). 
Another area of research within AD/HD and comorbid anxiety is examining 
anxiety among AD/HD subtypes.  In these studies, anxiety has often been subsumed 
under a broader construct of internalizing symptoms.  Significant differences among 
comorbid internalizing symptoms have been found among AD/HD subtype groups in 
some research and not in other research (August et al., 1996; Eiraldi, Power, & Nezu, 
1997; Willcutt et al., 1999).  Some studies have found comorbid internalizing problems to 
be equally associated with AD/HD-I and AD/HD-C, while other research has 
demonstrated comorbid internalizing problems to be more strongly associated with only 
AD/HD-I or AD/HD-C alone.  When studying AD/HD subtypes and patterns of 
comorbidity with anxiety specifically and not submerged in the category of internalizing 
disorders/symptoms, mixed results have also been found.  Levy, Hay, Bennett, and 
McStephen (2005) found that higher rates of anxiety disorders were associated with 
AD/HD-C compared to AD/HD-I.  Gender differences were also present with higher 
rates of anxiety among female children compared to male children.  However, no 
differences have been found between children with AD/HD-I and children with AD/HD-
C (Power, Costigan, Eiraldi, & Leff, 2004) and between genders in children with AD/HD 
(Gaub & Carlson, 1997) on levels of anxiety.  Higher rates of anxiety among children 
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with AD/HD-C and among female children with AD/HD may be explained by anxiety 
being associated with greater impairment.  AD/HD-C has been found to be a more severe 
disorder (i.e., greater number of symptoms among both hyperactivity-impulsivity and 
inattention dimensions, greater comorbidity, more academic problems) than AD/HD-I 
and AD/HD-HI in some studies (Faraone, Biederman, Weber, & Russell, 1998; Nolan, 
Volpe, Gadow, & Sprafkin, 1999; Wolraich, Hannah, Pinnock, Baumgaertel, & Brown, 
1996).  Research also suggests that although male children are more likely to be referred 
for evaluations, female children who are referred have more impairment (Eme, 1992).  
Nolan et al. (1999) found that within a group of children with AD/HD-C, female children 
had a greater number of symptoms in both inattention and hyperactive-impulsive 
dimensions, suggesting a more severe disorder.  Research has indicated that lower 
thresholds may be needed to detect AD/HD symptoms in female children because DSM-
IV symptom count criteria may underdiagnose female children who experience 
impairment and would benefit from further evaluation and treatment (Hinshaw, 2002; 
Waschbusch & King, 2006). 
Limitations of research 
Whereas research on children with AD/HD and comorbid anxiety has not 
investigated the question of whether or not anxiety experienced by children with AD/HD 
is comparable to that of children in the general population, research on AD/HD and 
comorbid anxiety has included the study of prevalence rates, patterns of AD/HD subtypes 
and comorbidity, and treatment outcome (August et al., 1996; Bird et al., 1993; Eiraldi et 
al., 1997; Faraone et al., 1998; Jensen et al. 2001; Nolan et al., 1999; Willcutt et al., 
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1999).  Although these studies contribute to furthering knowledge regarding AD/HD and 
anxiety, many questions are still left unanswered.  For example, when performing 
different analyses, some studies often do not differentiate between comorbid mood 
disorders and anxiety, labeling comorbidity simply as internalizing problems (August et 
al., 1996).  Also, when there is a distinction made between mood and anxiety difficulties, 
little is known about different types of anxiety disorders and some studies use only 
dimensional measures of anxiety (Eiraldi et al., 1997; Faraone et al., 1998; Nolan et al., 
1999).  As previously mentioned, the DSM-IV currently defines 10 clinical anxiety 
disorders that affect children (American Psychiatric Association, 1994).  Although there 
have been mixed results, Social Phobia and Generalized Anxiety Disorder have been two 
of the most prevalent anxiety disorders in the smaller portion of studies that have 
attempted to address the prevalence rates of anxiety disorders among children with 
AD/HD (Manassis et al., 2000; Willcutt et al., 1999).   
The current study attempts to target several of the shortcomings and ambiguous 
findings in research conducted so far addressing AD/HD and comorbid anxiety in 
children.  First, it describes anxiety disorder rates in a population of children with 
AD/HD who have been diagnosed using comprehensive DSM-IV criteria in attempt to 
replicate and clarify previous findings.  Thus, the participants were children who met full 
criteria for AD/HD, not simply symptom counts or absence of functional impairment.  
Second, the current study also attempts to clarify any differences in expression of levels 
of anxiety across AD/HD subtypes and/or between genders.  The literature reviewed has 
shown mixed results with some indications that greater anxiety may be associated with 
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children who may experience more impairing forms of the disorder, AD/HD-C and 
female children.  Finally, the current study takes the next step in this line of research by 
examining psychosocial factors that may predict the presence of anxiety in a clinic 
population of children with AD/HD using both dimensional and categorical measures of 
anxiety specifically and not “internalizing problems” in general.  Use of both dimensional 
and categorical measures are used to aid in clarifying optimal methods of measuring 
anxiety in this population. 
Conceptual Framework 
Because most research has been limited to studying prevalence rates of comorbid 
anxiety and examining patterns of AD/HD subtypes and internalizing comorbidity, the 
next important step to take is to examine factors that may explain AD/HD and the 
presence of comorbid anxiety in children.  Multiple pathways are likely to explain this 
particular comorbidity.  Anxiety may precede AD/HD or vice versa.  An alternative 
pathway may be that they develop concurrently.  An examination of how children with 
AD/HD are susceptible to the influences of the previously mentioned psychosocial risk 
factors for childhood anxiety is necessary and is where understanding the common 
association of these childhood disorders can begin as depicted in Figure 2.   
Because children with AD/HD have a disorder that is characterized by 
developmentally deviant levels of inattention and/or hyperactivity-impulsivity (American 
Psychiatric Association, 1994), they are inherently at risk for developing negative 
cognitions regarding control of their environment.  First, without interventions, children 
with AD/HD simply have great difficulty physically controlling themselves as many of 
          
 
27
their hyperactive-impulsive symptoms include behaviors such as fidgeting and squirming 
when seated, running around or climbing excessively in inappropriate situations, being 
"on the go" or acting as if "driven by a motor," and having difficulty waiting for a turn 
(American Psychiatric Association, 1994).  In addition, children with AD/HD may feel 
they have little control over their attention as they may struggle with inattentive 
symptoms that include behaviors such as having difficulty sustaining attention, making 
careless errors in one's work, and being easily distracted (American Psychiatric 
Association, 1994).  In turn, struggles with attention and impulsivity may make them 
vulnerable to adapting a negative cognitive style that not only affects their beliefs 
regarding control, but also contributes to a bias of making impulsive and automatic 
negative cognitive errors.   
Other difficulties that may increase vulnerability to cognitive processing 
distortions and encourage negative cognitions regarding control of their environments 
include poor academic functioning and social functioning.  Approximately 30-50% of 
children with AD/HD also have a learning disability (Barkley, 1990; Cantwell & Baker, 
1992; Klein & Mannuzza, 1991; Lambert & Sandoval, 1980).  Children with AD/HD 
experience increased academic failure including repeating a grade and contact with 
specialized services, such as academic tutoring and special classes compared to controls 
(Barkley, Anastopoulos, Guevremont, & Fletcher, 1991; Faraone et al., 1998).  The 
persistent patterns of inattentive, intrusive, and excessive behaviors that children with 
AD/HD demonstrate also disrupt social interactions frequently leaving them with fewer 
friends than other children, less liked than others, and rejected by their peers (Erhardt & 
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Hinshaw, 1994; Karustis, Power, Rescorla, Eiraldi, & Gallagher, 2000; Pelham & 
Bender, 1982).  Repeated struggles and failures in both academic and social functioning 
on a daily basis may make influential contributions to the perception of lack of control of 
their environment and use of negative cognitive errors in children with AD/HD. 
Research has also demonstrated that parents of children with AD/HD may also 
exhibit similar negative parenting practices and parent psychopathology to those of 
parents of anxious children.  Parents of children with AD/HD are more directive, giving 
more commands to them, are more critical toward them, are more negative, and are less 
likely to respond to social interactions initiated by them compared to parents of children 
without AD/HD (Barkley, 1990; Johnston & Mash, 2001).  Mothers of children with 
AD/HD also have exhibited increased rates of anxiety compared to mothers of children 
without AD/HD (Chronis et al., 2003; Perrin & Last, 1996).  August et al. (1996) found 
that mothers of children with AD/HD-only rated themselves as being more effective in 
disciplinary management and were less depressed than mothers of children with 
comorbid internalizing disorders.  Thus, parenting practices and maternal 
psychopathology may be risk factors among children with AD/HD for developing 
internalizing disorders and anxiety specifically.   
Research Questions and Hypotheses 
In brief review, many children with AD/HD also experience comorbid anxiety 
disorders.  Multiple pathways are likely responsible for AD/HD and comorbid anxiety; 
AD/HD may follow anxiety, the opposite may occur, or they may develop 
simultaneously.  Although a longitudinal study would best address the unfolding of 
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factors that promote the presence of anxiety in children with AD/HD, the practical and 
budgetary constraints made it unfeasible for the current study.  Alternatively, this study 
was designed as an initial step to begin addressing the question:  What psychosocial 
factors increase the risk for anxiety in a population of children whose primary diagnosis 
is AD/HD?  In addition, replicating and clarifying existing literature was addressed.  
Based on the conceptual and empirical literature previously reviewed, the following 
predictions were made: 
 
• Consistent with prior research, children with AD/HD were expected to exhibit 
Social Phobia and GAD more often than other anxiety disorders. 
 
• Due to experiencing both inattentive and hyperactive-impulsive symptoms, 
children with AD/HD-C often experience a higher degree of functional 
impairment than that associated with AD/HD-HI or AD/HD-I.  Similar findings 
have been reported for girls with AD/HD. To the extent that greater impairment is 
frequently associated with developing comorbid difficulties, this may suggest a 
link to greater susceptibility for anxiety problems.  Thus, higher levels of 
dimensional anxiety were expected to be found among children with AD/HD-C 
versus the other subtypes, as well as among girls versus boys regardless of 
subtype. 
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• Consistent with prior research and with the conceptual model presented earlier 
(Weems & Stickle, 2005), faulty thinking and parenting factors were expected to 
account for the greatest variance in both dimensional and categorical anxiety 
among children with AD/HD; to a lesser degree, school functioning, treatment, 
and demographic variables were expected to predict comorbid anxiety as well.  
Because it impairs daily functioning in ways that increase the risk for anxiety to 
occur, AD/HD symptomatology was also expected to explain variance in 
comorbid anxiety above and beyond that of the other variables.    
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CHAPTER II 
METHOD 
 
 
Participants 
 The present study used a clinical population of 63 children with AD/HD ranging 
in age from 8 to 12 years old and their mothers.  Child participants were recruited from 
current and former clients of the UNCG AD/HD clinic and former participants in AD/HD 
Research Lab studies who had undergone comprehensive evaluations resulting in a 
diagnosis of AD/HD.  They were identified as meeting DSM-IV criteria for AD/HD for 
this study based on a positive AD/HD diagnosis generated by maternal responses to the 
DISC-IV, accompanied by clinically significant scores on the attention problems and/or 
hyperactivity subscales of the BASC or ADHD Rating Scale – IV completed by parents.  
All three AD/HD subtypes were eligible.     
Thirty-eight male children with AD/HD and 25 female children with AD/HD 
participated in the study.  The participants’ mean age was 9.8 years.  Racial backgrounds 
represented that of the community with 76.2% Caucasian children, 20.6% African-
American children, and 3.2% biracial children participating in the study.  Their mothers’ 
mean age was 39.4 years.  This participant sample was similar to the population seen in 
the UNCG Psychology Clinic.  A summary of demographic variables and frequencies of 
AD/HD subtypes are summarized in Table 1. 
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Measures 
 Several measures were employed to determine diagnostic status of the children in 
order to qualify for participation in the study and also to determine AD/HD subtype for 
subsequent analyses.  Questionnaires assessing demographics, faulty thinking, parenting 
factors, school functioning, treatment, and AD/HD severity were selected and used to 
represent these domains in order to identify potential risk factors to predict association of 
anxiety in children with AD/HD. 
AD/HD Diagnostic Status 
 Computerized Diagnostic Interview Schedule for Children - IV. (DISC; NIMH, 
1997).  The DISC-IV is a computerized structured diagnostic interview that evaluates for 
DSM-IV Axis I disorders.  Responses to the interview are given in a yes/no format.  Each 
question is read aloud to the parent exactly as presented on the computer, and the 
administrator enters the exact responses without interpretation.  All aspects of the 
diagnosis are addressed.  The interview has been found to be a reliable and valid measure 
(Schwab-Stone et al., 1996; Shaffer, Fisher, Lucas, Dulcan, & Schwab-Stone, 2000).  
Maternal responses to the AD/HD module were used to assess the presence of AD/HD in 
children.   
Behavior Assessment System for Children. (BASC; Reynolds & Kamphaus, 
1992).  The BASC is a broad band rating scale, which consists of 109-148 items 
depending on the appropriate age form (child or adolescent in this study).  There are both 
teacher and parent report versions, which have been shown to be psychometrically sound 
(Merenda, 1996).  Each item is rated on a 4-point scale.  The measure yields 9 clinical 
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scales, 3 adaptive scales, and 4 composite scores.  The Hyperactivity and Attention 
Problems subscales were used to establish developmental deviance of these symptoms to 
aid in confirming AD/HD diagnoses.   
Attention-Deficit Hyperactivity Disorder Rating Scale - IV. (DuPaul, Power, 
Anastopoulos, & Reid, 1998).  The ADHD rating scale is an 18-item scale based on the 
DSM-IV criteria for AD/HD.  There are teacher and parent report versions.  This measure 
has been found to be a useful instrument for identification purposes in accordance with 
DSM-IV diagnostic criteria (DuPaul et al., 1998; DuPaul, et al., 1997) and has excellent 
reliability and validity (DuPaul et al. 1998).  Each item is rated on a 4-point scale.  The 
measure yields Inattentive, Hyperactive-Impulsive, and Total Scores, which were used to 
assess the developmental deviance of AD/HD symptoms in the children in order to 
confirm an AD/HD diagnosis.   
Predictor Variables 
Nowicki-Strickland Locus of Control Scale. (NSLOC; Nowicki & Strickland, 
1973).  This scale is a 40-item self-report measure designed to assess the degree of 
perceived control (success or failure) children think they have over the environment.  
Reliability and validity have been demonstrated (Kendall, Finch, Little, Chirico, & 
Ollendick, 1978; Nowicki & Strickland, 1973; Yates, Hecht-Lewis, Fritsch, & Goodrich, 
1994).  Responses are given in a yes/no format with higher scores indicating external 
locus of control.  This measure was used as an indicator of the extent children used an 
external locus of control in their thinking. 
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Children's Negative Cognitive Error Questionnaire. (CNCEQ; Leitenberg et al., 
1986).  This questionnaire asks children to rate vignettes illustrating four types of 
cognitive distortions or negative cognitive errors (catastrophizing, overgeneralization, 
personalization, and selective abstraction) in three areas (social, academic, and athletic).  
Internal consistency and test-retest reliability have been demonstrated (Leitenberg et al., 
1986).  Children use a 5-point scale to rate how similar a thought is to how they would 
think in the situation.  Total scores were used as an indicator of children’s use of negative 
cognitive errors.    
Parenting Stress Index - Short Form. (PSI-SF; Loyd & Abidin, 1985). The PSI-SF 
is a 36-item scale assessing parenting stress.  This measure has excellent reliability and 
validity (Loyd & Abidin, 1985).  Items are rated on a 5-point scale.  The index is 
comprised of three domains: parental distress, parent-child dysfunctional interaction, and 
difficult child.  The PSI-SF generates scores from each of these domains as well as a 
Total Stress Score.  For the purposes of the present study, the PSI-SF Total Stress Score 
served as a parenting stress variable.   
 Symptom Checklist - 90- Revised. (SCL-90R; Derogatis, 1993).  The SCL-90R is 
a 90-item scale assessing a broad band of psychological maladjustment in adults.  The 
SCL-90R has adequate internal consistency and test retest reliability and validity (Pauker, 
1999).  Items are rated on a 5-point scale.  The measure yields a General Severity Index 
Score and an anxiety subscale, which were employed in analyses.  The measure was used 
to assess for general psychopathology and also anxiety in mothers.    
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Alabama Parenting Questionnaire.  (APQ; Frick, Christian, & Wootton, 1999; 
Shelton, Frick, & Wootton, 1996).  The APQ consists of 35 items assessing five 
parenting constructs.  It includes a Parental Involvement scale, a Positive Parenting scale, 
a Poor Monitoring/Supervision scale, an Inconsistent Discipline scale, and a Corporal 
Punishment scale.  Items assessing the first two scales are worded in the positive 
direction and items assessing the last three scales are worded in the negative direction.  
The items are rated using a 5-point scale (1=never to 5=always).  The Parenting 
Composite score served as an indicator of negative parenting practices. 
Child and Family Information Sheet.  This form was completed by parents and 
designed to collect information on children’s school functioning and treatment history.  
To assess school functioning, the frequencies of those children with learning disabilities, 
repeating grades, and obtaining special education services (i.e. tutoring, attending special 
classes, attending resource classes) were gathered.  In addition, grades on their last report 
card served as a measure of academic performance.  Due to various grading scales among 
different grade levels, academic performance was identified as “satisfactory” or 
“unsatisfactory” for analyses.  Parents were also asked questions regarding their 
children’s therapy and medication treatment as well as their own mental health treatment 
history to control for treatment effects in the analyses.  Dichotomous groups were formed 
for analyses.  For example, children who had received medication treatment for their 
AD/HD symptoms were coded as “1” and those who had not were coded as “0.” 
Attention-Deficit/Hyperactivity Disorder Rating Scale - IV. (DuPaul, Power, 
Anastopoulos, & Reid, 1998).  See description above.  This measure yields Inattentive, 
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Hyperactive-Impulsive, and Total Scores which were used to assess the severity of 
AD/HD symptoms in children.  The adult self-report version was also completed by 
mothers to serve as a measure of their AD/HD symptomatology. 
Outcome Variables 
 The presence of anxiety in children with AD/HD was measured through several 
different formats.  Both parent and child perspectives were included.  In addition, both 
dimensional and categorical anxiety were assessed. 
Behavior Assessment System for Children. (BASC; Reynolds & Kamphaus, 
1992).  The Anxiety subscale from the parent version of the BASC was used as an 
outcome measure of dimensional anxiety.   
 Multidimensional Anxiety Scale for Children. (MASC; March, Parker, Sullivan, 
Stallings, & Conners, 1997).  The MASC is a 4-point Likert self-report scale that 
represents anxiety in children aged 8 to 18 years.  It has excellent internal reliability and 
satisfactory to excellent test-retest reliability.  It demonstrates both convergent and 
divergent validity (March et al., 1997; March & Sullivan, 1999).  The MASC consists of 
39 items distributed across 4 major factors, 3 of which can be divided into 2 subfactors 
each.  The factors include physical symptoms (tense/restless and somatic/autonomic), 
social anxiety (humiliation/rejection and public performance fears), harm avoidance 
(perfectionism and anxious coping), and separation anxiety.  An overall score is a valid 
indicator of generalized anxiety and was used as an outcome measure of dimensional 
GAD.   
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 Social Anxiety Scale for Children-Revised. (SASC-R; La Greca & Stone, 1993).  
The SASC-R is a 22-item scale that assesses three factors of child social anxiety: Fear of 
negative evaluation from peers; social avoidance and distress that is specific to new 
situations or unfamiliar peers; social avoidance and distress that is experienced more 
generally when with peers.  Research has supported both reliability and validity of this 
scale.  A self-report version uses a 5-point scale to rate how much each item is true for 
the child.  In this study, the total score served as a measure of dimensional Social Phobia. 
Computerized Diagnostic Interview Schedule for Children - IV. (DISC; NIMH, 
1997).  Parental responses to the anxiety modules (Social Phobia, Separation Anxiety 
Disorder, Specific Phobia, Panic Disorder, Agoraphobia, Generalized Anxiety Disorder, 
Obsessive-Compulsive Disorder, Posttraumatic Stress Disorder) were used to assess the 
presence of anxiety symptomatology in children and to determine categorical anxiety, 
specific anxiety diagnoses.   
Procedure 
Parents of current and former child clients of the UNCG AD/HD Clinic and 
former participants in AD/HD Research Lab studies who agreed to be contacted 
regarding potential participation in research projects were telephoned by the principal 
investigator in order to ascertain their interest in participation in the current study.  Of 
those clients who were currently obtaining services in the AD/HD clinic who qualified 
for the study, their therapists informed their parent(s) of the study after receiving 
evaluation feedback, and the principal investigator then followed up with a telephone call 
to the client’s parent if interested in hearing more about the study.  Depending on 
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convenience for the participant’s parent, research visits were conducted either at the 
UNCG Psychology Clinic or the participant’s home.  Before administering any 
assessment measures, the principal investigator explained the study in detail and obtained 
signed written consent from the parent and either the principal investigator or trained 
student assistant obtained and documented assent from the child.  The parent was given a 
copy of the consent form.   
In addition to the battery of interviews and questionnaires completed during 
evaluations of children for AD/HD in the UNCG AD/HD Clinic, this study added four 
written child self-report measures - the NSLOC, CNCEQ, SASC-R, and the MASC - and 
parent-completed anxiety modules of the DISC-IV.  For those children whose evaluations 
were recently completed, parents were not asked to complete again the overlapping 
measures between those used in their child’s evaluation and this study.  For those 
children whose evaluations were completed beyond six months before being recruited for 
this study, mothers again completed the AD/HD Rating Scale-IV and the BASC to assess 
the current severity of their children’s AD/HD symptoms and the status of comorbid 
anxiety.  Participant’s mothers were also administered the AD/HD and anxiety modules 
of the DISC-IV.  To assess other areas of parental functioning, mothers completed the 
Self-Report Version of the AD/HD Rating Scale-IV, the PSI-SF, the SCL-90R, and the 
APQ.  For those children who were recruited from prior AD/HD Research Lab studies, 
mothers were not asked to complete again the overlapping measures.  Thus, mothers 
completed three additional anxiety modules of the DISC-IV, the Self-Report Version of 
the AD/HD Rating Scale-IV, the PSI-SF, the SCL-90R, and the APQ.  All children 
          
 
39
completed the NSLOC, CNCEQ, SASC-R, and MASC.  These additional child self-
report measures were administered by either the principal investigator or a trained student 
assistant if available and were each read aloud to child participants to account for 
different reading levels.  The child-completed measures took approximately 45 minutes 
to 1 hour to administer.  Before ending the research visit, children were also allowed to 
choose a small toy from a toy box and parents were paid $10 as compensation for their 
participation. 
All administrations of the DISC-IV including those during the original 
evaluations and during the current study were conducted by doctoral students supervised 
by a licensed psychologist with a Ph.D. in clinical psychology who had received certified 
training in the administration of the DISC-IV.  Doctoral students received didactic 
training in administration of the DISC-IV and conducted pilot cases before actual 
administration to clients and study participants, and thus, all doctoral students had 
extensive experience with DISC-IV administration.   
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CHAPTER III 
RESULTS 
 
 
Preliminary Analyses 
 Table 2 presents various means, standard deviations, and ranges of the data 
representing predictor and outcome variables.  An examination of the distributions of 
each continuous variable, along with skewness and kurtosis statistics, revealed that the 
variables were approximately normally distributed with no significantly skewed variables 
or inflation of scores in the tails or centers of the distributions.  
Rates of Anxiety Disorders 
As seen in Table 3, the frequencies of the eight anxiety disorders assessed by  
the DISC are presented.  Social Phobia (22.2%) and GAD (11.1%) are listed as the 
second and third most common anxiety diagnoses in this population of children with 
AD/HD.  Because the DISC has been argued to produce false positive diagnoses of 
Specific Phobia, this disorder was not unexpectedly endorsed as the most common 
anxiety diagnosis (34.9%).  Overall, 50.8% of the children in this study were positive for 
a DISC anxiety diagnosis.   
Differences in Dimensional Anxiety by AD/HD Subtype and Gender 
 To aid in clarifying previous research studying subtype and gender differences in 
anxiety within AD/HD populations, a two-way factor analysis of variance (ANOVA) was 
conducted using the BASC anxiety subscale as the dependent variable.  Results of the 
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ANOVA are given in Table 4.  Within the analysis, only participants with AD/HD-IA or 
AD/HD-C were included as there were only two cases with AD/HD-HI, an insufficient 
number for the analysis.  Neither main effect of AD/HD subtype or gender was found to 
be significant.  However, there was a significant interaction effect of AD/HD subtype and 
gender on dimensional anxiety, F (1, 57) = 5.116, p < .05.  Simple effects analyses 
revealed that male children with AD/HD-C were rated significantly more anxious than 
male children with AD/HD-IA.   No other differences in anxiety were revealed by 
AD/HD subtype and gender.   
Inter-correlations Among Demographic, Predictor, and Outcome Variables 
 A summary of correlations is presented in Table 5.  Among predictor and 
outcome variables, gender (female) was associated with increased dimensional social 
anxiety (r = .28, p < .05).  Children who had more external locus of control were 
associated with increased dimensional generalized (r = .37, p < .01) and social anxiety (r 
= .52, p < .01).  Children who made more negative cognitive errors were also associated 
with having increased dimensional generalized (r = .45, p < .01) and social anxiety (r = 
.73, p < .01).  As parenting practices became more negative they were associated with an 
increase in BASC dimensional anxiety, r = .28, p < .05.  Children who had to repeat a 
grade in school were more likely to acquire a DISC diagnosis of Social Phobia, r = .39, p 
< .01.  Having at least one special education service was also associated with an increase 
in BASC dimensional anxiety (r = .25, p < .05) as well as MASC generalized anxiety (r = 
.25, p < .05) and a DISC diagnosis of Social Phobia (r = .27, p < .05).  Children who had 
therapy services were associated with an increase in BASC dimensional anxiety, r = .33, 
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p < .01.  Children whose mothers had therapy were more likely to have a DISC anxiety 
diagnosis, r = .29, p < .05.   
Among predictor variables, an increase in age was associated with a decrease in 
AD/HD severity (r = -.27, p < .05), decrease in Hyperactivity-Impulsivity severity (r = -
.33, p < .01), and decrease in external locus of control (r = -.32, p < .05).  Gender 
(female) was associated with increased academic performance (r = .25, p < .05).  Gender 
(male) was associated with having mothers with greater AD/HD symptom severity (r = -
.30, p < .05) and with mothers who had therapy (r = -.28, p < .05).  Children who used 
more external locus of control also made more negative cognitive errors, r = .41, p < .01.  
Increased parenting stress was associated with increased general psychopathology (r = 
.30, p < .05) and anxiety in mothers (r = .27, p < .05) as well as with negative parenting 
practices (r = .57, p < .01).  In addition, children with increased total AD/HD severity (r = 
.37, p < .01), Inattention severity (r = .29, p < .05), and Hyperactivity-Impulsivity 
severity (r = .34, p < .01), and children who had therapy (r = .36, p < .01) and medication 
treatment (r = .26, p < .05) were associated with increased parenting stress.  Increased 
general psychopathology in mothers was associated with negative parenting practices (r = 
.26, p < .05), increased anxiety in mothers (r = .82, p < .01), increased mother AD/HD 
severity (r = .55, p < .01), and mothers having had therapy (r = .44, p < .01) and 
medication treatment (r = .42, p < .01).  Anxious mothers were more likely to have 
greater AD/HD severity (r = .49, p < .01) and therapy (r = .31, p < .05) and medication 
treatment (r = .28, p < .05).  Mothers with increased AD/HD severity were more likely to 
have had therapy treatment (r = .35, p < .01) and medication treatment (r = .31, p < .05).  
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Having at least one special education service was associated with decreased academic 
performance (r = -.32, p < .05) and increased total AD/HD severity (r = .47, p < .01), 
Inattention severity (r = .42, p < .01), and Hyperactivity-Impulsivity severity (r = .40, p < 
.01).  Increased academic performance was associated with less Inattention severity, r = -
.25, p < .05.    
 Among outcome variables, increased BASC anxiety was significantly associated 
with the presence of at least one DISC anxiety diagnosis (r = .37, p < .01) including 
DISC GAD (r = .52, p < .01) and DISC Social Phobia (r = .29, p < .05).  Increases in 
SASCR social anxiety were associated with increases in MASC generalized anxiety, r = 
.65, p < .01.   
Notable correlations among demographic variables included race being associated 
with increased maternal psychopathology (r = .33, p < .05), repeating a grade (r = .25, p < 
.05), and dimensional social anxiety (r = .31, p < .05).   
Regression Analyses 
 As summarized in Table 6, predictor variables measuring the domains of 
demographics, faulty thinking, parenting factors, school functioning, treatment, and 
AD/HD severity were entered into hierarchical stepwise regressions and hierarchical 
forward stepwise logistic regressions to assess predictability of dimensional and 
categorical anxiety.  Multicollinearity was checked for and determined not a problem.  
Predictor Variables and Dimensional Anxiety 
 To determine the variance explained by the predictor variables in dimensional 
anxiety as measured by the BASC anxiety subscale, a hierarchical stepwise regression 
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analysis was conducted.  Results of the regression are presented in Table 7.  In the first 
step, the demographic variables (age and gender) were entered into the regression and 
were not significant in explaining variance in dimensional anxiety.  Thus, they were 
excluded from the model as were the faulty thinking variables (NSLOC total score and 
CNCEQ total score) entered in step 2 which were also not significant.  In step 3, the 
parenting factors variables were entered as a block (parenting stress, maternal general 
psychopathology, maternal anxiety, maternal AD/HD severity, negative parenting 
practices).  Negative parenting practices as measured by the APQ Parenting Composite 
emerged as a significant predictor and was retained in subsequent steps (Adj. R2 = .060, p 
< .05).  In step 4, school functioning variables (learning disabilities, repeating grades, 
special education services, and academic performance) were entered into the regression 
model.  Special education services were found to account significantly for an additional 
6.1 % of the variance in dimensional anxiety above and beyond that of negative parenting 
practices (Cum. Adj. R2 = .121 , p < .05).  In step 5, treatment variables (child therapy, 
child medication, maternal therapy, and maternal medication) were entered, and none was 
significant in explaining the variance in dimensional anxiety resulting in removal from 
the model.  In the final step, AD/HD severity variables (ADHD-RS-IV total score, 
inattention score, and hyperactivity-impulsivity score) were entered, but were not 
significant in explaining any additional variance above and beyond that of negative 
parenting practices and special education services.  Overall, the combination of negative 
parenting practices and special education services accounted for 12.1% of the variance in 
dimensional anxiety.   
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Predictor Variables and Dimensional GAD 
To determine the variance explained by the predictor variables in dimensional 
GAD as measured by the MASC total score, a hierarchical stepwise regression analysis 
was conducted.  Results of the regression are presented in Table 8.  Using the same 
measures in the same order as the predictor variables in the above regression analysis, the 
demographic variables were entered into the regression first and were not significant.  In 
step 2, the faulty thinking variables (NSLOC total score and CNCEQ total score) were 
entered to predict dimensional GAD.  Children’s negative cognitive errors (CNCEQ total 
score) emerged as a significant predictor in explaining dimensional GAD and was 
retained in the model (Adj. R2 = .187, p < .01).  Parenting factors, school functioning 
variables, treatment variables, and AD/HD severity variables were then entered into the 
regression as steps 3, 4, 5, and 6, respectively.  None of these variables was significant in 
explaining any additional variance above and beyond that of children’s negative 
cognitive errors in predicting dimensional GAD.  Overall, children’s negative cognitive 
errors accounted for 18.7% of the variance in dimensional GAD.   
Predictor Variables and Dimensional Social Phobia 
To determine the variance explained by the predictor variables in dimensional 
Social Phobia as measured by the SASCR total score, a hierarchical stepwise regression 
analysis was conducted.  Results of the regression are presented in Table 9.  Using the 
same measures in the same order as the predictor variables in the above regression 
analysis, the demographic variables (age and gender) were entered first to predict 
dimensional Social Phobia.  Gender (female children) emerged as a significant predictor 
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and was retained in subsequent steps (Adj. R2 = .065, p <.05).  In step 2, the faulty 
thinking variables (NSLOC total score and CNCEQ total score) were entered.  Both 
children’s negative cognitive errors (CNCEQ total score) and children’s locus of control 
(NSLOC total score) resulted as significant predictors in explaining dimensional Social 
Phobia and were retained in the model (Cum. Adj. R2 = .561, p < .01; Cum. Adj. R2 = 
.625, p < .01).  Parenting factors were then entered as a block (parenting stress, maternal 
general psychopathology, maternal anxiety, maternal AD/HD severity, negative parenting 
practices) in step 3.  Maternal general psychopathology emerged as a significant predictor 
(Cum. Adj. R2 = .646, p < .05).  School functioning variables, treatment variables, and 
AD/HD severity variables were then entered into the regression as steps 4, 5, and 6, 
respectively.  None of these variables was significant in explaining any additional 
variance above and beyond that of gender, children’s faulty thinking, and maternal 
psychopathology in predicting dimensional Social Phobia.  Overall, gender (female 
children), children’s faulty thinking, and maternal psychopathology accounted for 64.6% 
of the variance in dimensional Social Phobia.   
Predictor Variables and Any Anxiety Diagnosis 
To determine the ability of the variables in this model to predict the presence or 
absence of any anxiety disorder as measured by the DISC, a hierarchical forward 
stepwise logistic regression analysis was performed.  Results are presented in Table 10 
and Table 11.  Using the same measures in the same order as the predictor variables in 
the above regression analyses, the demographic variables, faulty thinking variables, 
parenting factors, and school functioning variables were entered into the regression as 
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steps 1, 2, 3, and 4, respectively, to predict the presence or absence of any DISC anxiety 
disorder.  None of these variables was significant in predicting the presence or absence of 
any DISC anxiety disorder and were removed from the model.  In step 5, treatment 
variables (child therapy, child medication, maternal therapy, and maternal medication) 
were entered, and maternal therapy was found to be significant and retained in the model 
(X2 = 4.883, p < .05).  In the final step, AD/HD severity variables were entered, but were 
not significant in adding any predictive ability above and beyond that of maternal therapy 
to the presence or absence of any DISC anxiety disorder.  Overall, mothers having 
therapy treatment accounted for 7.8% of the variance in predicting any DISC anxiety 
disorder above and beyond that of chance.  Children whose mothers had had therapy 
treatment were 3.35 times more likely to have a DISC anxiety diagnosis.  Maternal 
therapy correctly predicted absence of an anxiety disorder 75.9% of the time and 
presence of an anxiety disorder 51.6% of the time with overall predictive ability of 
63.3%.   
Predictor Variables and GAD Diagnosis 
To determine the ability of the variables in this model to predict the presence or 
absence of GAD as measured by the DISC, a hierarchical forward stepwise logistic 
regression analysis was performed.  Using the same measures in the same order as the 
predictor variables in the above logistic regression analysis, none of the predictor 
variables was found to be significant.  Thus, none of the predictor variables significantly 
improved predicting GAD above and beyond that of chance. 
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Predictor Variables and Social Phobia Diagnosis 
To determine the ability of the variables in this model to predict the presence or 
absence of Social Phobia as measured by the DISC, a hierarchical forward stepwise 
logistic regression analysis was performed.  Results are presented in Table 12 and Table 
13.  Using the same measures in the same order as the predictor variables in the above 
logistic regression analyses, the demographic variables, faulty thinking variables, and 
parenting factors were entered into the regression as steps 1, 2, and 3, respectively, to 
predict the presence or absence of Social Phobia.  None of these variables was significant 
in predicting Social Phobia resulting in removal from the model.  In step 4, school 
functioning variables (learning disabilities, repeating grades, special education services, 
and academic performance) were entered into the logistic regression model, and repeating 
grades emerged as significant (X2 = 18.180, p < .01).  Treatment variables and AD/HD 
severity variables were then entered into the regression as steps 5 and 6, respectively.  
None of these variables was significant in adding any predictive ability above and beyond 
that of repeating grades to the presence or absence of Social Phobia.  Overall, children 
who have repeated a grade in school accounted for 26.1% of the variance in predicting 
Social Phobia above and beyond that of chance.  Children who had repeated a grade were 
17 times more likely to have a DISC diagnosis of Social Phobia.  Repeating grades 
correctly predicted absence of Social Phobia 95.7% of the time and presence of Social 
Phobia 50% of the time with overall predictive ability of 85%.   
 
 
          
 
49
Differences in Dimensional and Categorical Anxiety by Child Medication Status 
 To clarify whether or not child medication status affected significant findings in 
regression analyses, child medication status was examined to determine if differences in 
dimensional anxiety and categorical anxiety existed simply due to medication treatment 
of AD/HD symptoms.  Appropriate t-tests and chi-square tests were run and no 
significant differences in child anxiety resulted between the two medication groups.  
Thus, children who had been treated with medication for their AD/HD symptoms did not 
significantly differ from those children not taking medication in their level of anxiety, 
measured either dimensionally or categorically. 
 
 
 
 
 
 
 
 
 
 
 
          
 
50
CHAPTER IV 
DISCUSSION 
 
 
Children with AD/HD develop difficulties with anxiety at a higher rate than the 
general population.  Determining what processes may underlie this difference in rates of 
anxiety development is important to add to the existing research on children with AD/HD 
and comorbid anxiety, which currently focuses mainly on rates of anxiety comorbidity 
and patterns of anxiety/internalizing symptoms among AD/HD subtypes.  Given that 
multiple pathways may lead to the co-occurrence of AD/HD and anxiety in children, this 
study’s overall goal was to examine the factors that may link these two disorders in a 
clinical AD/HD population.  In particular, this study asked:  What psychosocial factors 
increase the risk for comorbid anxiety in children with AD/HD?  Three hypotheses 
related to this question were investigated to clarify understanding of comorbid anxiety in 
children with AD/HD.   
Hypothesis One   
Consistent with prior research, children with AD/HD were expected to exhibit 
Social Phobia and GAD more often than other anxiety disorders.  
Replicating previous research, children in this study were positive for anxiety 
disorders at a higher rate than the general population with 50.8% of the children meeting 
DISC criteria for at least one anxiety diagnosis.  Hypothesis One was supported in that 
Social Phobia and GAD were found to be the second and third most common anxiety 
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disorders, respectively, in this population of children with AD/HD.  As mentioned earlier, 
Specific Phobia was endorsed as the most common anxiety disorder.  However, without 
additional clinical interviewing, the DISC tends to overdiagnosis this type of anxiety 
disorder due to many of the fears assessed being developmentally appropriate for children 
of this age (e.g., fear of the dark).   
Hypothesis Two   
Due to experiencing both inattentive and hyperactive-impulsive symptoms, 
children with AD/HD-C often experience a higher degree of functional impairment than 
that associated with AD/HD-HI or AD/HD-I.  Similar findings have been reported for 
girls with AD/HD. To the extent that greater impairment is frequently associated with 
developing comorbid difficulties, this may suggest a link to greater susceptibility for 
anxiety problems.  Thus, higher levels of dimensional anxiety were expected to be found 
among children with AD/HD-C versus the other subtypes, as well as among girls versus 
boys regardless of subtype. 
Although there were no significant main effects of AD/HD subtype or gender on 
dimensional anxiety as measured by the BASC, a significant interaction between these 
two independent variables did exist; male children with AD/HD-C were more anxious 
than male children with AD/HD-IA.  Thus, the hypothesis was partially supported in 
regard to subtype, but only in male children.  Contrary to the hypothesis, there were no 
gender differences in anxiety.  However, this finding is consistent with research on 
childhood anxiety with levels of anxiety being relatively equal until adolescence when 
girls generally experience increased anxiety compared to boys, a stage somewhat later in 
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development than that experienced by the child participants in this study.  The findings of 
the current study may also aid in explaining mixed results in past AD/HD studies as all-
male samples have been often used.  Thus, gender composition of the samples may be 
critical in finding significant differences in anxiety among subtypes.  Differences among 
anxiety levels may exist among subtypes in all-male samples but not in samples including 
boys and girls.  
Hypothesis Three 
Consistent with prior research and with the conceptual model presented earlier 
(Weems & Stickle, 2005), faulty thinking and parenting factors were expected to account 
for the greatest variance in both dimensional and categorical anxiety among children 
with AD/HD; to a lesser degree, school functioning, treatment, and demographic 
variables were expected to predict comorbid anxiety as well.  Because it impairs daily 
functioning in ways that increase the risk for anxiety to occur, AD/HD symptomatology 
was also expected to explain variance in comorbid anxiety above and beyond that of the 
other variables.    
Three separate hierarchical stepwise regression analyses were conducted using 
predictor variables representing six domains (demographics, faulty thinking, parenting 
factors, school functioning, treatment, and AD/HD severity) and three different 
dimensional anxiety outcome variables (BASC anxiety, MASC anxiety, and SASCR 
anxiety).  In the first analysis, both negative parenting practices and special education 
services were significant in predicting BASC anxiety.  Thus, those children whose 
mothers used more negative, critical parenting practices characterized by poorer 
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involvement in children’s activities, poorer monitoring and supervision of children, more 
inconsistent in applying discipline, and greater use of corporal punishment were more 
likely to develop dimensional anxiety.  This is consistent with the conceptual framework 
presented earlier in which it was suggested that mothers of children with AD/HD use 
similar negative parenting practices as those used by mothers of anxious children, and 
thus, may put children with AD/HD at greater risk of developing anxiety problems.  In 
addition, children obtaining special education services, such as tutoring, special classes, 
and/or resource classes, were more likely to show greater anxiety, above and beyond that 
of having mothers who used negative parenting practices.  Because school functioning is 
often negatively affected by AD/HD symptoms, children with AD/HD frequently need 
special education services and may feel self-conscious about experiencing learning 
difficulties leading to greater anxiety.  The other school functioning variables, learning 
disabilities, repeating grades, and academic performance, were not significant in 
predicting dimensional anxiety.  Compared to these variables, receiving special education 
services may have been a significant predictor due to this measure of school functioning 
being more “visible” to children leading those with AD/HD who receive special 
education services to be more aware of being different than those children with AD/HD 
not receiving special education services.    
In the second analysis, children’s negative cognitive errors were significant in 
predicting dimensional GAD.  So, children who tended to make more negative cognitive 
errors such as catastrophizing, overgeneralization, personalization, and selective 
abstraction were more likely to experience generalized anxiety.  Because of their 
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impulsivity and the daily impairment they experience in various areas, children with 
AD/HD may quickly jump to faulty conclusions and be at risk for employing this type of 
thinking style which has been implicated as a potential causal factor in childhood anxiety.   
In the third analysis, female gender, children’s negative cognitive errors, 
children’s locus of control, and maternal psychopathology were significant in predicting 
dimensional Social Phobia.  Thus, girls may be more at-risk than boys for developing 
anxiety problems at least when measuring social anxiety.  This finding may appear 
contrary to the findings in Hypothesis 2 where no gender differences were found 
measuring anxiety with the BASC.  However, the difference in findings is likely due to 
different forms of anxiety being measured, social anxiety and more general trait anxiety.  
Perhaps, girls with AD/HD are more socially impaired than boys with AD/HD due to 
social norms making it more acceptable for boys to be hyperactive.  Thus, because girls 
with AD/HD appear so different from typical girls, they may experience repeated social 
failures more often than boys resulting in feeling more socially anxious.  Children’s 
faulty thinking, making negative cognitive errors and having an external locus of control, 
was also predictive of dimensional Social Phobia, demonstrating an expected link 
between children with AD/HD and anxiety.  As stated earlier, children with AD/HD may 
be susceptible to making impulsive conclusions about situations and develop a feeling of 
life being out of their personal control as a result of daily impairment in interpersonal and 
school functioning.  In respect to maternal psychopathology as a significant predictor, 
past research has indicated that parent anxiety is associated with greater anxiety in 
children, but not associated with the development of specific anxiety disorders in children 
          
 
55
(Pine, 1999).  Although, in this analysis, maternal psychopathology in general and not 
anxiety specifically predicted dimensional Social Phobia in children with AD/HD, 
maternal functioning is still supported as playing a role in their child’s anxiety. 
 In sum, when accounting for variance in dimensional anxiety, the hypothesis that 
the domains of faulty thinking and parenting factors would result as the most influential 
predictive factors was partially supported.  At least one predictor variable in one of these 
domains emerged as significant in explaining variance in each of the three dimensional 
outcome variables.  In fact, these predictor variables are the only ones that emerged as 
significant except for obtaining special education services (predicting 6.1% of the 
variance in BASC anxiety) and female gender (predicting 6.5% of the variance in 
dimensional Social Phobia).  The domains of faulty thinking and parenting factors were 
both represented in producing the models that explained the greatest amount of variance 
in dimensional anxiety.   
Three separate hierarchical forward stepwise logistic regression analyses were 
also conducted using predictor variables representing the same six domains 
(demographics, faulty thinking, parenting factors, school functioning, treatment, and 
AD/HD severity) and three different categorical anxiety outcome variables 
(presence/absence of any DISC anxiety disorder, presence/absence of DISC GAD, 
presence/absence of DISC Social Phobia).  The analyses examining categorical anxiety 
are more challenging to interpret.  In the first analysis, whether or not mothers received 
therapy was significant in predicting the presence/absence of any DISC anxiety disorder.  
Children whose mothers had received therapy were 3.35 times more likely to have a 
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DISC anxiety diagnosis.  This may indirectly indicate that mothers receiving treatment 
had been experiencing more severe psychological difficulties, but not reporting them at 
the time of study participation due to experiencing some relief from obtaining treatment.  
Their children may have been identified as positive for DISC anxiety diagnoses for 
various reasons including truly having a diagnosis or mothers having a bias for endorsing 
symptoms in their children as a result of their own distress.  Past research has also shown 
that parents with their own anxiety difficulties reward more anxious and avoidant 
behavior in their anxious children (Barrett, Rapee, Dadds, & Ryan, 1996), which 
perpetuates their children’s anxiety problems.   
In the second analysis, none of the variables representing the six domains was 
significant in predicting the presence/absence of DISC GAD.  Although children positive 
for DISC GAD represented one of the most common anxiety diagnoses in this sample, 
only seven children actually were identified with GAD which may have provided limited 
variability to find significant results.    
In the third analysis, whether or not children repeated a grade emerged as 
significant in predicting the presence/absence of DISC Social Phobia.  Children who 
repeated a grade were 17 times more likely to have a DISC Social Phobia diagnosis.  
Similar to special education services and dimensional anxiety, perhaps children with 
AD/HD who repeated grades were concerned that their peers were more aware of their 
school difficulties than of children with AD/HD who did not repeat grades leading them 
to be more anxious in their interaction with peers.  From a different perspective, because 
direction cannot be determined from the correlational nature of the research design and 
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analyses, children with AD/HD and Social Phobia may be at risk for repeating grades.  
These children may have social anxiety that may make them miss school more often or 
simply impair their learning and academic performance so severely that they are required 
to repeat grades. 
 Unlike the regression analyses using dimensional anxiety outcome variables, the 
domains of faulty thinking and parenting factors were not supported as significant 
predictors in the development of categorical anxiety.  Thus, the hypothesis was inaccurate 
in regard to explaining categorical DISC anxiety diagnoses.  Only two variables emerged 
as significant in accounting for variance in categorical anxiety, maternal therapy and 
repeating grades.  In addition, AD/HD severity was not significant in explaining variance 
in dimensional or categorical anxiety above and beyond the other variables, indicating 
that it may make an indirect rather than direct contribution to the development of anxiety.  
In sum, faulty thinking variables and parenting factors appear to be most consistent in 
predicting anxiety measured dimensionally rather than categorically in children with 
AD/HD.   
Synthesis of Findings 
Consistent with previous research on children with AD/HD (Anderson et al., 
1987; Angold et al., 1999; August et al., 1996; Biederman et al., 1992; Bird et al., 1993; 
Busch et al., 2002; Cohen et al., 1993; Jensen et al., 1997; Russo & Biedel, 1994), 50.8% 
of the children in this study were identified as having an anxiety disorder as measured by 
the DISC representing a higher rate than in the general population.  As hypothesized, 
Social Phobia and GAD were two of the most frequent comorbid anxiety disorders in this 
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population.  These findings lend support to prevalence rates found in past studies.  
Finding no gender differences in BASC anxiety in this age group is consistent with 
research examining anxiety alone.  For clinical purposes, being aware that both female 
and male children with AD/HD are at risk for comorbid anxiety is important so that it is 
not ignored in either population.  However, potentially due to experiencing greater 
impairment, male children with combined type AD/HD may be at greater risk for 
comorbid anxiety relative to male children with the inattentive type. 
Overall, this study lends support to faulty thinking variables and parenting factors 
being links to the development of anxiety in a population of children with AD/HD as 
represented in the etiological model presented in Figure 2.  Children who tend to have a 
faulty thinking style, live in a more restrictive environment with negative parenting, and 
have mothers with greater psychopathology were predictive of experiencing more 
dimensional anxiety, and thus, may be at greater risk for developing anxiety problems.  It 
is not surprising that the faulty thinking and parenting factor domains were significantly 
represented in predicting dimensional anxiety in children with AD/HD as these 
relationships are also indicated in the research on childhood anxiety alone (Chorpita & 
Barlow, 1998; Chorpita et al., 1998).  The AD/HD severity domain did not directly 
explain any additional variance in dimensional or categorical anxiety.  Because these 
children had diagnoses of AD/HD, there may have not been enough variability in the 
AD/HD predictor variables to achieve significance in predicting anxiety.  Or, it can be 
concluded that the core AD/HD symptoms simply make no direct impact on the 
development of anxiety.  Rather, they may affect other factors as visually depicted in 
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Figure 2, such as impairing school functioning and parenting practices which in turn may 
lead to an increase in faulty thinking and therefore contribute to anxiety difficulties.   
Both dimensional and categorical measures of anxiety were examined as outcome 
variables in the analyses of this study.  Based on the results of this study, potential risk 
factors were more consistent in predicting dimensional anxiety rather than categorical 
anxiety.  Further, the risk factors identified using dimensional anxiety outcome measures 
were more consistent with past childhood anxiety research.  The two significant 
predictors in the regression analyses using categorical outcome measures of anxiety were 
actually better at predicting the absence rather than the presence of anxiety.  In addition, 
risk factors explained more variance in predicting dimensional measures of specific 
forms of anxiety rather than anxiety in general.  Thus, based on the results, measuring 
anxiety dimensionally targeting specific types of anxiety may produce a more accurate 
picture when determining the developmental pathways of children with AD/HD.    
Finally, results indicated that school functioning may also play an important role 
in the development of anxiety in this AD/HD population.  Whether or not a child had 
repeated a grade, a measure of the school functioning domain, was predictive of DISC 
Social Phobia.  Repeating a grade, coupled with special education services also being a 
significant predictor of BASC dimensional anxiety, lends support to school functioning 
being a possible risk factor that should be further studied to understand its role in 
facilitating the development of anxiety in children with AD/HD.   
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Implications for Clinical Practice 
 The findings of this study can aid in guiding evaluations of children who are 
demonstrating behaviors suggestive of AD/HD as well as potential treatments for 
children with AD/HD who experience difficulties beyond the core symptoms.  Clinicians 
should be aware that children referred for AD/HD evaluations often have comorbid 
difficulties and these additional problems should be adequately addressed through 
appropriate assessments including those that can clarify the presence of any anxiety 
problems.  This study lends support to including child-report measures to assess for 
anxiety in addition to parent-report measures as children may be more accurate in 
describing this internalizing problem.  Early identification of comorbid anxiety and 
timely treatment may reduce the negative impact on daily functioning of these children 
and prevent additional difficulties such as depression from occurring.  Because faulty 
thinking and parenting factors were indicated as possible risk factors in this study, 
treatments including cognitive-behavioral therapy as well as parent training may be 
beneficial to these children and families.  Treating children with AD/HD who also have 
anxiety difficulties with stimulant medications alone in many cases would only be 
effective in improving the core AD/HD symptoms.  Multi-modal treatment is clearly 
indicated in this specific population which is consistent with current research on 
treatments for children with AD/HD. 
Limitations 
  One of the limits of this study is that it used a correlational research design.  Thus, 
conclusive causal statements cannot be made.  The possible risk factors identified in this 
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study may be responsible for anxiety as etiological factors, maintenance factors, or a 
combination of both.  Thus, a longitudinal study would be ideal for examining more 
thoroughly the risk factors that contribute to the development of anxiety in children with 
AD/HD.  It would also be helpful in determining the timing of the development of the 
disorders, although it is likely that it is different for different children; core symptoms of 
anxiety may precede the development of AD/HD, the opposite may occur, or the 
disorders may develop simultaneously.  Further, as the symptom pattern of AD/HD 
changes as children age, how is comorbid anxiety affected?  Does the pattern of risk 
factors change as children age?  Are there different outcomes in impairment if both 
disorders are treated as early as possible?  Due to time and budgetary constraints a 
longitudinal study was not possible for the current study. 
 Another limitation in this study is that the child participants who were identified 
as having an anxiety disorder categorically were not rated overall as clinically anxious by 
the dimensional measures of anxiety.  Similarly, mothers did not rate themselves as 
significantly stressed, anxious, or with general psychopathology.  This may suggest that 
children with AD/HD are at greater risk for developing anxiety disorders but a milder 
form of anxiety disorders than that of the general population.  Results and interpretation 
may have been different with a population of children with more severe comorbid anxiety 
who have mothers with more severe psychopathology.  Stronger relationships among 
more of the predictor and outcome variables may have emerged (e.g., mother anxiety and 
child anxiety).  Because this study used a clinical population of children with AD/HD as 
participants, results cannot be generalized to all children with AD/HD in the general 
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population.  Because not all children with AD/HD seek services, unknown biases may 
exist in this sample of children who did seek AD/HD evaluations. 
 For some of the analyses, increasing the number of participants would have 
increased power to find significant results that may truly exist.  For example, when 
examining differences in anxiety by AD/HD subtype and gender, a greater number of 
participants may have aided in finding a significant main effect of AD/HD subtype as it 
approached significance (See Table 4) with current numbers.  Likewise, a greater number 
of participants would have increased the variability to determine if any significant 
relationships between predictor and outcome variables were overlooked. 
 Another limitation of the study was the measure of academic performance within 
the school functioning domain.  Because the child participants spanned ages (8 through 
12 years old) and grade levels (1st through 7th grades), academic performance as 
measured by grades was coded as satisfactory/unsatisfactory.  In school, younger children 
received labels as grades (i.e., satisfactory, needs improvement) while older children 
received letter grades.  Thus, the measure of academic performance in this study was not 
standardized and was more of an estimate of academic functioning. 
 Although this study attempted to use both child and mother report measures to 
represent predictor and outcome variables to gain a more complete understanding of the 
development of anxiety in this population, again due to time constraints, equal 
representation of child report and mother report was unfeasible for this study.  Given that 
children may be better reporters of internal processes, such as making negative cognitive 
errors and using an external locus of control, it is not surprising that these predictor 
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variables were significant in dimensional GAD anxiety and dimensional Social Phobia as 
these outcome measures were also child report measures.  In addition, obtaining teacher-
report questionnaires of childhood AD/HD and anxiety at the time of the study would 
have added to understanding in the school setting.  On a similar vein, all measures used to 
assess anxiety were either in questionnaire or interview format.  To obtain a more 
thorough measure of anxiety in this population, other assessment methods such as 
physiological measures, observation, and/or parent-child interactions could have aided in 
providing a clearer overall picture of anxiety.  
Conclusion 
Despite these limitations, this study adds to the research literature on children 
with AD/HD and comorbid anxiety.  Consistent with past research, children with AD/HD 
in this study were shown to exhibit anxiety disorders at higher rates than the general 
population.  This study added to the AD/HD literature in measuring comorbid anxiety 
both dimensionally and categorically, specifically demonstrating that Social Phobia and 
GAD were two of the most common anxiety disorders in this population.  Results also 
supported anxiety differences among AD/HD subtypes with greater anxiety occurring in 
male children with AD/HD-C compared to male children with AD/HD-I.  Even more 
importantly, this study examined factors to aid in determining the link between children 
with AD/HD and comorbid anxiety, identifying potential risk factors for the development 
of anxiety in this particular population.  Results most consistently supported variables 
represented in the faulty thinking and parenting factor domains, and to a lesser degree in 
the school functioning domain, as possible risk factors affecting the developmental 
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pathway of anxiety in children with AD/HD.  Although AD/HD severity made no direct 
contribution to comorbid anxiety above and beyond the other variables, it most likely 
makes an indirect contribution by its impact on the faulty thinking, parenting factor, and 
school functioning domains.  
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Appendix A. Tables 
 
 
 
 
 
Participant 
 
 
Variable 
 
 
Child 
  
 Mean Age 9.8 
  
Gender 
 
 Male  38 (60.3%) 
 Female 25 (39.7%) 
  
Race 
 
 Caucasian 48 (76.2%) 
 African American 13 (20.6%) 
 Biracial 2 (3.2%) 
  
AD/HD Subtype 
 
 Inattentive Type 29 (46.0%) 
 Hyperactive-Impulsive Type 2 (3.2%) 
 Combined Type 32 (50.8%) 
 
Mother   
 Mean Age 39.4 
 
 
 
 
 
 
 
 
 
Table 1 
Demographic Variables and AD/HD Subtypes 
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Variable 
 
 
Male 
 
Female 
 
Frequency  
(%) no 
 
 
(%) yes 
 
M 
 
SD 
 
Min 
 
Max 
 
Predictor         
Child Age     9.83 1.41 8 12 
Gender 38 25       
NSLOC     16.95 4.66 7 34 
CNCEQ     51.41 16.96 24 90 
PSITOT     86.97 23.53 44 144 
SCLSEV     57.77 9.78 32 79 
SCLANX     53.15 10.72 37 79 
Maternal AD/HD     14.85 10.17 0 42 
APQPC     -2.21 2.78 -8.00 5.73 
LD   82.5 17.5     
Repeat Grd   79.4 20.6     
Special Ed Ser   54 46     
AcadPerf   20.6 79.4     
Child Therapy   57.1 42.9     
Child Med   11.1 88.9     
Maternal Therapy   63.5 36.5     
Maternal Med   52.4 47.6     
MTOT     35.97 10.02 17 54 
MIA     20.19 4.45 10 27 
MHI     15.78 7.06 0 27 
Outcome         
MBANX     54.25 11.06 34 86 
MASC     54.73 11.44 28 89 
SASCR     45.43 15.58 18 82 
DISCanxdx   49.2 50.8     
DISCgad   88.9 11.1     
DISCsopho 
 
  77.8 22.2     
Table 2 
Description of Predictor and Outcome Variables 
Note.  NSLOC = Nowicki-Strickland Locus of Control Scale total score; CNCEQ = Children’s Negative Cognitive Error Questionnaire total score; 
PSITOT = Parenting Stress Index total stress score; SCLSEV = Symptom Checklist – 90 – Revised general severity index t-score; SCLANX = Symptom 
Checklist – 90 – Revised anxiety subscale t-score; Maternal AD/HD = ADHD Rating Scale – IV – Self-Report Version maternal AD/HD total severity for 
past 6 months; APQPC = Alabama Parenting Questionnaire parenting composite score; LD = learning disorder ; RepeatGrd = repeated a grade; 
SpecEdSer = special education services; AcadPerf = satisfactory academic performance; Child Therapy = child therapy treatment; Child Med = child 
medication treatment; Maternal Therapy = maternal therapy treatment; Maternal Med = maternal medication treatment; MTOT = child total AD/HD 
severity on ADHD Rating Scale – IV; MIA = child inattention severity on ADHD Rating Scale – IV; MHI = child hyperactivity-impulsivity severity on 
ADHD Rating Scale – IV; MBANX = BASC anxiety t-score; MASC = Multidimensional Anxiety Scale for Children total t-score; SASCR = Social 
Anxiety Scale for Children – Revised total score; DISCanxdx = any DISC anxiety diagnosis; DISCgad = DISC diagnosis of Generalized Anxiety 
Disorder; DISCsopho = DISC diagnosis of Social Phobia. 
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Anxiety Disorder 
 
 
Frequency (%) 
 
Specific Phobia 
 
34.9 
Social Phobia 22.2 
Generalized Anxiety Disorder 11.1 
Separation Anxiety Disorder 9.5 
Obsessive-Compulsive Disorder 1.6 
Posttraumatic Stress Disorder 0 
Panic Disorder 0 
Agoraphobia 0 
 
Any DISC Anxiety Disorder 
 
 
50.8 
Table 3 
Rates of Anxiety Disorders as Measured by the Diagnostic Interview 
Schedule for Children-IV (DISC) 
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Source 
 
 
df 
 
MS 
 
F 
 
p 
 
Gender 
 
1 
 
178.934 
 
1.674 
 
.201 
Subtype 1 349.265 3.268 .076 
Gender * Subtype 1 546.743 5.116 .028 
Error 
 
57 106.864   
Table 4 
Two-Way ANOVA for Dimensional Anxiety as a Function of 
AD/HD Subtype and Gender 
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STEP DOMAIN PREDICTOR VARIABLES 
1 Demographics Age 
Gender 
 
2 Faulty Thinking 
 
NSLOC 
CNCEQ 
 
3 Parenting Factors PSI total score 
SCL-90R: General Severity, Anxiety 
Adult ADHD Rating Scale total 
APQ Parenting Composite 
 
4 School Functioning Learning disability, Repeating grade, 
Special education services, Academic 
Performance 
 
5 Treatment Child Therapy 
Child Medication 
Maternal Therapy 
Maternal Medication 
 
6 AD/HD Severity ADHD Rating Scale – IV: Total 
score, Inattention severity,  
Hyperactivity-Impulsivity severity 
 
Table 6 
Predictor Variables Entered into Hierarchical Regression Analyses 
Note.  NSLOC = Nowicki-Strickland Locus of Control Scale total score; CNCEQ = Children’s Negative 
Cognitive Error Questionnaire total score; PSI = Parenting Stress Index total stress score; SCL-90R = Symptom 
Checklist – 90 – Revised general severity index t-score, anxiety subscale t-score; Adult ADHD Rating Scale total 
= ADHD Rating Scale – IV – Self-Report Version maternal AD/HD total severity for past 6 months; APQ = 
Alabama Parenting Questionnaire parenting composite score.   
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STEP 
 
 
VARIABLES ENTERED 
 
STD 
BETA 
 
ADJUSTED 
R2 
 
F CHANGE 
 
 
p 
 
1 
 
Negative parenting practices 
 
 
.275 
 
.060 
 
4.840 
 
<.05 
 
2 
 
Negative parenting practices 
Special education services 
 
 
.293 
.273 
 
.121 
 
5.062 
 
<.05 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Table 7 
Summary of Hierarchical Stepwise Regression Model Predicting 
Dimensional Anxiety 
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STEP 
 
 
VARIABLES ENTERED 
 
STD 
BETA 
 
ADJUSTED 
R2 
 
F CHANGE 
 
 
p 
 
1 
 
 
Negative cognitive errors 
 
 
.447 
 
.187 
 
14.765 
 
<.001 
Table 8 
Summary of Hierarchical Stepwise Regression Model Predicting 
Dimensional GAD 
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STEP 
 
 
VARIABLES ENTERED 
 
STD 
BETA 
 
ADJUSTED 
R2 
 
F CHANGE 
 
 
p 
 
1 
 
Gender 
 
 
.284 
 
.065 
 
5.174 
 
<.05 
 
2 
 
Gender 
Negative cognitive errors 
 
 
.216 
.707 
 
.561 
 
67.787 
 
<.001
 
3 
 
Gender 
Negative cognitive errors 
Locus of control 
 
 
.235 
.588 
.287 
 
.625 
 
10.918 
 
<.01 
 
4 
 
 
 
Gender 
Negative cognitive errors 
Locus of control 
Maternal psychopathology 
 
 
.257 
.569 
.315 
.163 
 
.646 
 
4.324 
 
<.05 
 
 
 
 
 
 
 
 
 
Table 9 
Summary of Hierarchical Stepwise Regression Model Predicting 
Dimensional Social Phobia 
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Variable 
 
β 
 
SE 
 
Odds ratio 
 
p 
 
Maternal Therapy 
 
 
1.210 
 
.563 
 
3.352 
 
.032 
Constant -.383 .335 .682 .253 
 
Table 10 
Logistic Regression Predicting Having Any Anxiety Diagnosis 
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Predicted 
 
 
 
 
 DISC   anxiety
 
diagnosis 
 
Percentage 
Observed  no yes Correct 
 
DISC anxiety diagnosis 
 
no
 
22 
 
7 
 
75.9 
 yes 15 16 51.6 
Overall Percentage    63.3 
Table 11 
Classification of Predicted Any Anxiety Diagnosis 
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Variable 
 
β 
 
SE 
 
Odds ratio 
 
p 
 
Repeating Grade 
 
 
2.833 
 
.903 
 
17.000 
 
.002 
Constant -1.580 .415 .206 <.001 
 
Table 12 
Logistic Regression Predicting Having Social Phobia Diagnosis 
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Predicted 
 
 
 
 
Social   Phobia
 
diagnosis 
 
Percentage 
Observed  no yes Correct 
 
Social Phobia diagnosis 
 
no
 
44 
 
2 
 
95.7 
 yes 7 7 50.0 
Overall Percentage    85.0 
Table 13 
Classification of Predicted Social Phobia Diagnosis 
          
 
98
Appendix B. Figures 
 
Figure 1. A general model of the etiology of childhood anxiety disorders based on 
Weems and Stickle (2005). 
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Figure 2. AD/HD added in dashed lines to depict a pathway of the development of 
AD/HD and comorbid anxiety based on Weems and Stickle (2005) model of anxiety. 
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Appendix C. Consent Forms 
 
THE UNIVERSITY OF NORTH CAROLINA 
GREENSBORO 
 
CONSENT TO ACT AS A HUMAN PARTICIPANT: 
 
Form for Parents/Guardians of Child Participants 
 
Project Title:  Factors Associated with the Development of Anxiety Among Children with 
Attention-Deficit/Hyperactivity Disorder 
 
Project Director:  Elizabeth McGee 
 
Parent's Name: ______________________________  Date of Birth: ____________ 
 
Participant's Name: ___________________________  Date of Birth: ____________ 
 
Date of Consent: _________________ 
 
Purpose: 
Many children with AD/HD go on to develop secondary problems including difficulties with 
anxiety or worrying a lot about things in their lives.  The purpose of this study is to aid in 
identifying risk factors for the development of anxiety among children with AD/HD.  By 
identifying risk factors early in children's lives, certain treatments can then be used in specific 
areas of their lives to prevent the development of anxiety. 
 
Procedure: 
Your child will be asked to complete written questionnaires that will be read to them by a trained 
research assistant.  These questionnaires will assess what they think about their environments 
including social, academic, and athletic scenarios.  In addition, ideas about how their peers and 
authority figures perceive them will be measured.  Finally, their report of physical symptoms will 
be collected, i.e., feelings of tension, restlessness.  These questionnaires should take about one 
hour to complete.  Your child will have the option to refuse to answer questions at any time. 
 
This research project also requires a parent or caregiver to complete an interview and 
questionnaires.  To assess the current severity of your child's AD/HD symptoms and the status of 
additional anxiety, you will complete two paper and pencil questionnaires on your child's 
behavior.  In addition, a trained graduate student researcher will administer an interview to assess 
these behaviors.  To assess other areas of parental functioning, you will complete questionnaires 
asking questions about your opinion of your child and your own psychological functioning.  
These questionnaires and interview should take about an hour to complete. 
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Risks and Discomforts: 
The risks involved in this study are minimal.  You and your child will be asked many personal 
questions regarding everyday life and how you respond in different situations.  You or your child 
may feel uncomfortable or embarrassed when answering particular questions about personal 
information.  If you feel uncomfortable at any time during the interview or when answering items 
on questionnaires, please notify the researcher immediately.  If you continue to feel 
uncomfortable after sharing your concerns, you may withdraw from the study at any time without 
any consequences.  If your child becomes uncomfortable or upset while answering the 
questionnaires, your child will also be given the option of withdrawing from the study at any time 
without any consequences.  
 
Although the information collected during the interview and via questionnaires is kept 
confidential, the researcher will examine items that may indicate the possibility of you or your 
child endangering yourselves.  For example, a researcher is required by law to report suspected 
physical abuse, sexual abuse, or other types of victimization.  Should such a situation arise, the 
researcher will first discuss this with you.  Emergency personnel or agencies will be provided if 
services are needed.  
 
Benefits: 
Children, families, schools, and society in general can benefit from this research.  Children with 
AD/HD are at a much higher risk for developing difficulties with anxiety than children without 
AD/HD.  This research can aid in determining more specifically factors that contribute to the 
development of anxiety in children with AD/HD, and thus, treatment can be aimed at lessening 
these effects and aid in preventing this comorbid difficulty.  In addition, you will be mailed a 
summary of the results of the study, and suggestions for possible treatments and agencies that 
provide these services. 
 
Confidentiality: 
The answers to questions given by you and your child during the assessment visit will be kept 
confidential.  As already mentioned, there may be a few cases in which the researcher cannot 
guarantee confidentiality.  If the researcher learns of physical or sexual abuse that has not already 
been reported, the researcher must report this information to the Department of Social Services.  
In addition, if the researcher believes your child is in danger, the researcher is required by law to 
report this to the Department of Social Services.  Again, you and your child have the right to 
refuse to answer questions at any time. 
 
The data collected in this study will be identified by research numbers only and no individual's 
name will be directly associated with the data.  It will be entered into password protected 
computer files.  The original data will be stored in locked filing cabinets for 5 years and at that 
time the data will be shredded. 
 
Consent: 
By signing this consent form, you agree that you understand the procedures and any risks and 
benefits involved in this research.  You and your child are free to participate or to withdraw your 
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consent to participate in this research at any time without penalty; your participation is entirely 
voluntary.  Your privacy will be protected because you will not be identified by name as a 
participant in this project. 
 
The research and this consent form have been approved by the University of North Carolina at 
Greensboro Institutional Review Board, which insures that research involving people follows 
federal regulations.  Questions regarding your rights as a participant in this project can be 
answered by calling Dr. Beverly Maddox-Britt at (336) 334-5878.  Questions regarding the 
research itself should be directed to Elizabeth McGee (334-5665, ext.2) or Dr. Arthur 
Anastopoulos (256-0006).  Any new information that develops during the project will be 
provided to you if the information might affect your willingness to continue in the project.   
 
By signing this form, you are agreeing to participate and to allow your child to participate in this 
project.  Your child will also be given a description of the project.  After hearing this, your child 
will be given the opportunity to give assent for participating in the project. 
 
 
 
______________________________  __________________________ 
Parent/Guardian signature   Witness to signature  
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ORAL PRESENTATION 
(When Obtaining Child Assent) 
 
 
Some children develop problems like worrying a lot about things in their lives.  The purpose of 
this study is to learn more about children’s worrying.  
 
You will be asked to complete written questionnaires that will be read to you by a trained 
research assistant.  These questionnaires will assess what you think about home, school, sports, 
and your friends.  In addition, ideas about how you think about how your friends, classmates, 
parents, and teachers think about you will be measured.  Finally, your report of feeling tense or 
restless will be collected.  These questionnaires should take about one hour to complete.  You will 
have the option to refuse to answer questions at any time. 
 
You will be asked many personal questions regarding everyday life and how you respond in 
different situations.  You may feel uncomfortable or embarrassed when answering particular 
questions about personal information.  If you feel uncomfortable at any time during the interview 
or when answering items on questionnaires, please tell me immediately.  If you continue to feel 
uncomfortable, you may withdraw from the study at any time.   
 
If you should tell me something that makes me think that you may endanger yourself, I will 
contact your parent to ensure your safety.   
 
Your answers to questions will be kept confidential.  The data collected in this study will be 
identified by research numbers only and your name will not be directly associated with the data.  
It will be entered into password protected computer files.   
 
 
 
 
 
 
 
 
Signature of person obtaining consent on behalf of the University of North Carolina at 
Greensboro 
 
____________________ 
 
Date  
 
 
